American Express uvádí, že AI by klientům mohla usnadnit maximalizaci odměn z platebních karet; firma by stejnou technologii mohla využít k lepšímu pochopení chování klientů a úpravě nabídek.
American Express Co (NYSE:AXP) is preparing for a new challenge as artificial intelligence makes it easier for consumers to optimize credit card rewards.
CEO Stephen Squeri acknowledged that AI could help cardholders extract more value from benefits, potentially forcing issuers to rethink how they manage perks, spending thresholds and loyalty economics.
AI Changes the Rewards GameSpeaking on the company’s third-quarter earnings call, Squeri said consumers have always been able to optimize spending across cards, but AI could make that behavior more sophisticated.
"With AI, as it might allow people to game a little more, it also will allow us to manage it a little bit better as well by using AI tools to understand what people are doing," Squeri said.
The remarks came in response to KBW analyst Sanjay Sakhrani, who asked how AmEx would respond if consumers increasingly directed spending toward whichever card offered the highest rewards.
Squeri acknowledged that rewards optimization is already common. "We’ve got a lot of gaming today that goes on, and it’s part of the overall mix," he said.
The emerging risk is that AI assistants could make it easier to compare benefits, identify lucrative offers and allocate purchases across multiple cards. For issuers, that could complicate the economics of rewards programs if customers become more effective at using benefits without generating corresponding incremental spending.
AmEx did not quantify the potential financial impact of AI-driven rewards optimization.
Why AmEx Thinks It Has an EdgeSqueri argued that AmEx’s business model extends beyond points and cash-equivalent rewards. The company competes through access, service, security and its relationships with both cardholders and merchants.
"Our overall model is so much more than just about points," he said.
AmEx also has ways to limit the cost of benefits. Squeri pointed to spending thresholds on the Platinum Card, saying the company can require customers to reach certain levels of spending before qualifying for specific benefits, reducing opportunities to game the system.
AI could give the company another way to identify behavior patterns and adjust its offers. However, Squeri cautioned that the situation is still developing, leaving the eventual impact on card member services expenses uncertain.
The Stakes for InvestorsThe issue matters because AmEx’s premium-card strategy relies on making membership attractive while maintaining profitable customer relationships. In the third quarter, net card fees grew 17% on a foreign-exchange-adjusted basis, supported by the U.S. Platinum refresh, while U.S. consumer spending increased 9.4% year-over-year.
Those figures do not establish that AI is affecting rewards costs today. Instead, they show why managing the balance between generous benefits, customer engagement and profitability matters as AI changes consumer behavior.
For investors, the key question is whether AmEx can use AI to personalize benefits and deepen loyalty without allowing rewards optimization to erode program economics. The same technology that helps customers maximize value could help issuers respond — but the financial outcome remains an open question.
Read Next
Photo: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Vrt Nargis-2 společnosti Chevron v egyptské části Středozemního moře potvrdil plynonosné vrstvy a objevil další vrstvu s čistou mocností plynu až 35 metrů.
Key Takeaways CVX's Nargis-2 well in Egypt confirmed existing gas reservoirs and encountered another gas-bearing interval.Drilled beyond 5,000 meters, the well found net gas pay of up to 35 meters, supporting further appraisal.Commercial success hinges on recoverable resources, project costs, capital needs and production timelines. Chevron Corporation (CVX - Free Report) has made further progress in assessing its offshore natural gas opportunity in Egypt after the Nargis-2 well delivered positive drilling results in the Mediterranean Sea. In an Oct. 24 announcement, Egypt’s Ministry of Petroleum and Mineral Resources said the well confirmed the continuation of gas-bearing reservoirs identified earlier and encountered another gas-bearing interval. The results give Chevron and its partners more information for evaluating the discovery, but additional work is required before a commercial development decision can be made.
Nargis-2 was drilled to a depth of more than 5,000 meters, and technical evaluation found net gas pay of up to 35 meters. The well also tested deeper geological layers, including formations associated with high pressure and temperature. Together, these findings help geologists build a clearer picture of the subsurface and assess whether the gas-bearing zones can support a viable project. However, the reported thickness is not a measure of total gas reserves, and it does not establish how much gas could ultimately be recovered.
Nargis-2 Expands the Evaluation ProgramDrilling began in May 2026, with Chevron working alongside its partners and the Egyptian Natural Gas Holding Company (“EGAS”). The well was planned to investigate the extent of the Nargis discovery and test additional formations below the intervals previously encountered. The presence of another gas-bearing layer is an encouraging result because it adds to the geological information available for the next stage of appraisal.
The latest update does not provide a revised estimate of the field’s resources or confirm a development schedule. Chevron and its partners will need to interpret the well data, assess reservoir characteristics and determine the technical and financial requirements of a potential development. Such work is especially important for offshore projects, where drilling, subsea facilities and supporting infrastructure can require significant investment. Until the appraisal results are translated into a development plan, the timing and scale of future production remain uncertain.
Chevron's Partnership Gives It a Role in Future DevelopmentChevron operates the Nargis area with Eni, Mubadala Energy and Egypt’s Tharwa Petroleum. The current contractor interests are 45% for Chevron, 30% for Eni through its subsidiary IEOC, 15% for Mubadala Energy and 10% for Tharwa Petroleum. The contractor group works with EGAS, which holds a 50% share in the concession structure.
The ownership mix gives Chevron an operating role in evaluating the discovery while spreading participation across several energy companies. Mubadala Energy completed its acquisition of a 15% interest from Eni in February 2026, leaving it with a 30% contractor interest. The companies will need to coordinate technical studies and future investment decisions as the project moves through appraisal. The partners' participation is not, on its own, evidence that a final investment decision has been made.
Why the Results Matter for Egypt's Gas SupplyEgypt’s petroleum ministry has identified the development of previously discovered but undeveloped resources as a priority. The policy aims to encourage exploration partners to continue investing and to move discoveries toward recoverable reserves and eventual production. If Nargis proves commercially viable, it could contribute to domestic natural gas supply and support Egypt’s broader efforts to develop offshore resources.
For Egypt, the key question is whether the field can be developed at a cost and pace that make sense under prevailing market conditions. More domestic gas production could provide an additional supply source, but that outcome depends on the volume of recoverable gas, the infrastructure required and the time needed to bring the asset online. The latest well results are a step in that process, not a guarantee of future output.
What CVX Investors Should MonitorFor Chevron investors, Nargis-2 adds a potential long-term growth opportunity to its international portfolio. A successful project could eventually contribute to production, but the announcement does not quantify the impact on Chevron’s earnings, cash flow or capital spending. It would therefore be premature to treat the drilling results as an immediate financial catalyst.
The next developments to watch are an updated assessment of the discovery, details on recoverable resources, the proposed development approach and any timeline for commercial production. Investors should also look for clarity on expected capital requirements and project economics. These factors will help establish whether the discovery can progress from geological promise to a project that creates value for Chevron and its partners.
Overall, Nargis-2 has delivered encouraging evidence that the known gas-bearing formations extend further and that an additional interval may be worth evaluating. The findings strengthen the case for continued appraisal, while leaving the field’s commercial scale and development prospects open. For now, Chevron has more data to work with; a clearer view of the asset’s value will depend on the technical and commercial conclusions that follow.
CVX's Zacks Rank & Other Key PicksCurrently, CVX sports a Zacks Rank #1 (Strong Buy).
Investors interested in the energy sector might consider other top-ranked stocks, such as Marathon Petroleum (MPC - Free Report) , Delek US Holdings (DK - Free Report) and Canadian Natural Resources Limited (CNQ - Free Report) , each sporting a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Marathon Petroleum is valued at $133.48 billion. The company is a leading U.S. independent refiner, marketer and transporter of petroleum products, with a strong refining footprint and an extensive midstream business. Marathon Petroleum benefits from its integrated operations, strategic refining assets and diversified earnings streams across the energy value chain.
Delek US Holdings is valued at $4.56 billion. It is a diversified downstream energy company engaged in petroleum refining, renewable fuels, asphalt production and logistics operations. Delek US Holdings operates multiple refineries in the United States and is committed to delivering safe, reliable energy while investing in cleaner energy initiatives.
Canadian Natural Resources is valued at $113.15 billion. It is an independent energy company. Canadian Natural Resources is engaged in the exploration, development, production and marketing of crude oil, natural gas and natural gas liquids.
Synopsys zvýšil výhled tržeb pro fiskální rok 2026 na 9,69–9,74 miliardy USD; opakované příjmy tvořily ve 3. čtvrtletí 82 % tržeb a objem nevyřízených zakázek dosáhl 10,9 miliardy USD.
Key Takeaways SNPS is automating engineering workflows across silicon-to-system design using AI agents.Recurring revenues accounted for 82% of fiscal Q3 2026 revenue, while backlog reached $10.9 billion.SNPS raised fiscal 2026 revenue guidance to $9.69-$9.74 billion.
Synopsys (SNPS - Free Report) is benefiting from rising demand for advanced chip design, verification and simulation tools as AI infrastructure expansion increases semiconductor and system-level engineering complexity. The company is integrating AI across its electronic design automation (EDA), verification and simulation portfolio to automate engineering workflows, improve productivity and accelerate chip development.
The integration of Ansys has further expanded its capabilities into multiphysics engineering, while growing demand for specialized chips, multi-die architectures and advanced packaging is creating additional growth opportunities. Currently, Synopsys is pursuing a multi-layered AI strategy focused on automating complex engineering tasks and expanding the use of its underlying design tools.
SNPS has introduced AgentEngineer, a portfolio of domain-specific, long-horizon AI agents built on its Autopilot Platform to automate engineering workflows across silicon-to-system design. The platform combines orchestration, persistent memory, engineering context and security to support more autonomous workflows. Synopsys is also collaborating with OpenAI to develop GPT-Synopsys for chip design, while its agreement with Amazon expands the use of its silicon IP, EDA, simulation and AI-powered engineering technologies for custom chips and AWS infrastructure.
Synopsys' growth strategy is supported by recurring revenues, a substantial backlog and improving cash generation. Recurring revenues accounted for 82% of total revenues in the third quarter of fiscal 2026, while backlog stood at $10.9 billion at the end of the quarter. EDA revenues grew 8.5% year over year, and Design IP returned to growth, supported by demand for interface, memory and die-to-die IP.
SNPS raised its fiscal 2026 revenue guidance to $9.69-$9.74 billion and expects EDA growth to accelerate to double digits for the full year. However, elevated debt following the Ansys acquisition, the ongoing recovery in Design IP margins, competitive pressures and customer concentration remain important risks.
How Competitors Fare Against SNPSSynopsys operates in a highly competitive EDA market, with major rivals, including Cadence Design Systems Inc. (CDNS - Free Report) and Keysight Technologies (KEYS - Free Report) . These companies serve different stages of the electronic and IC design lifecycle, offering specialized tools and solutions that help customers improve product development, design efficiency and testing.
Keysight Technologies competes primarily across electronic design, measurement and testing, with software and solutions covering areas such as electromagnetic analysis, circuit simulation and hardware verification. Meanwhile, Cadence Design Systems is benefiting from increasing design complexity and growing customer investments in AI-powered automation.
Cadence is also strengthening its position through its expanding Cadence.ai portfolio. New offerings, including AgentStack, ChipStack, ViraStack and InnoStack AI Super Agents, are broadening the company’s AI capabilities across the design workflow and could help Cadence maintain its momentum as AI adoption accelerates.
SNPS’ Price Performance, Valuation and EstimatesShares of SNPS have lost 8.4% year to date compared with the Computer - Software industry’s decline of 1%.
SNPS YTD Performance Chart
Image Source: Zacks Investment Research
From a valuation standpoint, SNPS trades at a forward price-to-sales ratio of 7.53X, higher than the industry’s average of 6.27X.
The Zacks Consensus Estimate for SNPS’ fiscal 2026 earnings is pegged at $15.14, indicating 17% year-over-year growth. Estimates have been revised upward in the past seven days.
Image Source: Zacks Investment Research
SNPS currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Proti společnosti Baidu byla podána hromadná žaloba kvůli údajnému klamání investorů ohledně jejího podnikání v oblasti AI a tržeb; její ADS se 18. srpna 2026 během seance propadly o 12,73 %.
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies institutional investors in Baidu, Inc. (NASDAQ: BIDU) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between November 18, 2025 and August 17, 2026. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
BIDU American Depositary Shares closed at $90.87 on August 18, 2026, a single-session decline of $13.25 per share, or 12.73%, on unusually heavy volume, and far below the Class Period high of $162.52 reached on January 22, 2026. To be considered for lead plaintiff, investors must file by November 13, 2026.
Notice to Institutional Holders
The pleading asserts that Baidu repeatedly told the market its AI-powered business was offsetting steep declines in legacy search advertising revenue. As averred in the action, that offset was allegedly insufficient and unsustainable, and total revenue was reasonably likely to decline. Fiscal 2025 total revenue fell 3% year over year to RMB 129.1 billion ($18.46 billion), and second quarter 2026 revenue declined 4% year over year.
The complaint charges that the Company's annual report stated it was not aware of any trends or uncertainties reasonably likely to have a material adverse effect on total revenue, a representation plaintiffs allege lacked a reasonable basis.
ERISA and Fiduciary Considerations
"Institutional investors play a critical role in securities class actions, and the alleged gap between Baidu's assurances about its AI transition and the revenue results later reported is precisely the type of issue fiduciaries are expected to evaluate. Funds with substantial documented losses are often best positioned to oversee a matter of this scale." -- Joseph E. Levi, Esq.
Fiduciary Obligations and Recovery Options
Plan trustees and investment committees are generally expected to consider whether identified securities claims represent recoverable plan assets rather than unclaimed value.Eligibility depends on purchases made during the November 18, 2025 through August 17, 2026 Class Period, not on whether the position is still held.Institutional loss analysis typically consolidates activity across custodians, sub-advisors, commingled vehicles, and separately managed accounts.Passive China-technology and ADR mandates may hold BIDU without actively monitoring pending U.S. securities litigation.Lead plaintiff appointment provides direct oversight of counsel, litigation strategy, and any proposed settlement, without increasing an individual claimant's share of recovery. Contact us to learn more about institutional recovery options or call (212) 363-7500.
INSTITUTIONAL INVESTOR REPRESENTATION — Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the BIDU Lawsuit
Q: When did Baidu, Inc. allegedly mislead investors? A: The Class Period runs from November 18, 2025 to August 17, 2026. The complaint alleges that corrective disclosures revealed information that caused a significant stock decline.
Q: What court was the BIDU class action filed in? A: The case was filed in the United States District Court for the Southern District of New York, governed by the Private Securities Litigation Reform Act of 1995.
Q: Who are the defendants named in the BIDU lawsuit? A: The complaint names Baidu, Inc. and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential eligibility.
Q: What if I already sold my BIDU shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.
Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
T-Mobile (TMUS - Free Report) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Here are three of the most important factors that make the stock of this wireless carrier a great growth pick right now.
Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for T-Mobile is 36.6%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.9% this year, crushing the industry average, which calls for EPS growth of 13.5%.
Cash Flow GrowthWhile cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.
Right now, year-over-year cash flow growth for T-Mobile is 3%, which is higher than many of its peers. In fact, the rate compares to the industry average of -0.6%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 6.3% over the past 3-5 years versus the industry average of 0.4%.
Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for T-Mobile have been revising upward. The Zacks Consensus Estimate for the current year has surged 3.3% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made T-Mobile a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that T-Mobile is a potential outperformer and a solid choice for growth investors.
Návštěvnost webu Costco z vyhledávání pomocí AI rostla druhé čtvrtletí po sobě trojciferným tempem a dosáhla nejvyššího konverzního poměru ze všech zdrojů.
Key Takeaways Costco's AI-driven search traffic grew at a triple-digit rate for the second straight quarter.AI-driven sales are rising at a triple-digit pace, with appliances, electronics and memberships leading.Costco's 16.4% stock gain tops the industry's 13.2% rise, but its premium valuation warrants caution. Costco Wholesale Corporation (COST - Free Report) is witnessing a notable shift in online shopping behavior as artificial intelligence increasingly shapes how consumers discover products. Although AI-driven search remains a relatively small channel compared with traditional sources of website traffic, its growing adoption is opening new opportunities for the warehouse retailer to connect with shoppers and drive online purchases.
On its fourth-quarter fiscal 2026 earnings call, Costco reported that traffic reaching its website through AI searches grew at a triple-digit rate for the second consecutive quarter. More importantly, this traffic continued to deliver the highest conversion rate among all sources visiting its site. Management stated that sales originating from searches conducted through AI tools, including those offered by OpenAI, Anthropic and Gemini, were growing at a triple-digit pace.
Appliances and consumer electronics lead purchases originating from AI searches, broadly mirroring Costco’s overall e-commerce mix. Memberships are also among the leading items discovered through these searches, suggesting shoppers are finding not just products but the retailer’s membership proposition.
Costco sees an advantage in AI-driven product discovery because it does not use paid digital advertising. The company is working with large language model providers to improve product data and website pages so its offerings appear clearly in search results. While the channel remains in its early stages, the strong growth in traffic and sales, coupled with high conversion rates, highlights its potential to become a more important source of online purchases.
How Are WMT and BJ Leveraging AI to Drive Digital Growth?Walmart Inc. (WMT - Free Report) is using AI to make digital shopping more personalized and convenient. Walmart said usage of its AI-powered Sparky assistant increased 70% year over year, while customers using Sparky spend 40% more per order. Walmart also highlighted Sparky’s ability to build meal plans, recommend products and recognize prior purchases across stores and online, helping shoppers avoid duplicate purchases and simplifying product discovery.
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) is also deepening digital engagement through AI-enabled shopping support. BJ’s Wholesale said its AI-powered assistant, Bev, has handled more than 100,000 member conversations, helping shoppers find products, check club hours and better use their memberships. BJ’s Wholesale is pairing this capability with broader digital convenience, as digitally enabled comparable sales rose 30% in the second quarter of fiscal 2026 and digitally engaged members demonstrated stronger spending and loyalty.
How Does Costco Stack Up Against Its Industry?Costco stock has climbed 16.4% year to date compared with the industry’s rise of 13.2%.
Image Source: Zacks Investment Research
What Does Costco’s Current Valuation Suggest?Costco's forward 12-month price-to-earnings ratio stands at 43.55, higher than the industry’s ratio of 28.91. However, it is trading below its 12-month median level of 44.36, indicating some moderation in valuation.
Image Source: Zacks Investment Research
What Do Earnings Estimates Signal for Costco?The Zacks Consensus Estimate for Costco’s current fiscal-year sales and earnings per share implies year-over-year growth of 8.4% and 11%, respectively. For the next fiscal year, the consensus estimate indicates a 7.2% rise in sales and 9.8% growth in earnings.
Image Source: Zacks Investment Research
Costco’s Investment CaseCostco’s strong membership loyalty, expanding digital capabilities and growing AI-driven engagement support its long-term growth prospects. However, the emerging AI-search opportunity remains relatively small, while the stock’s premium valuation warrants caution despite encouraging earnings expectations. Investors may prefer a balanced approach at the current juncture. Costco currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Verizon nabízí ze srovnávaných titulů nejvyšší dividendový výnos, 6,18 %; dividendy ve 2. čtvrtletí představovaly přibližně 46 % volného peněžního toku ve výši 6,43 mld. USD.
Social Security's 3.6% COLA keeps your benefit moving, but your brokerage account has to fend for itself. Three dividend stocks not only clear that income bar but also carry the coverage ratios to prove the payout can last.
Social Security benefits rise 3.6% under the cost-of-living adjustment taking effect in 2027. The raise is applied to the check each retiree already gets, so it helps the benefit keep up with prices. It does nothing for the savings in a brokerage account. To grow your income alongside that benefit, you need dividend payers whose cash flow can support a steady, rising payout. Each of the three stocks below yields more than the COLA figure, and each passed a coverage check before yield was considered.
First, a COLA and a yield measure different things, as a COLA is a percentage increase on a benefit you already receive. On a hypothetical $2,000 monthly check, a 3.6% adjustment adds $72 a month. A dividend yield is the cash a stock pays each year divided by its current share price, and a yield alone can’t tell you whether the payout will grow or even last. So the COLA works here as a reference point for how fast a retiree’s income is rising, and each dividend still has to be judged on whether the business can pay for it.
PepsiCo: Global Brands Funding a Dividend That Has Risen Every Year in the Record PepsiCo (NASDAQ:PEP | PEP Price Prediction) sells snacks, foods and drinks in more than 200 countries and territories. Its brands include Pepsi, Lay’s, Doritos and Gatorade. At $136.28, the stock yields 4.13%. Part of that yield comes from a falling share price. The stock is down 6.41% over the past year and trades well below its 52-week high of $166.41.
Dividend safety: PepsiCo paid $5.80 per share in dividends against trailing EPS of $7.95, a payout ratio of about 73% of earnings. Free cash flow coverage is lower. The free cash flow yield of 4.15% roughly matches the dividend yield, so the business generates about enough free cash to pay its dividend. Management plans to return $8.9B to shareholders this year, including $7.9B in dividends. It is also targeting free cash flow conversion of at least 80%. Debt is manageable: operating earnings cover interest expense 10.26x.
Track record: PepsiCo’s dividend history goes back to 1999, and the quarterly payout steps up every year in that record. The latest quarterly payment is $1.48, up from $1.4225. That sets the forward annual dividend at $5.92.
Bull case: International growth is making up for a weak U.S. snack business. In the latest quarter, adjusted EPS of $2.34 beat the $2.30 estimate. Revenue rose 5.6% to $25.27B, and LatAm Foods grew 14%. People keep buying chips and sports drinks in a downturn, which gives retirees a steady source of cash to lean on.
Risk: North American snacks remain under pressure. Core operating profit in that segment fell 12%, and rising input costs led management to cut its core EPS growth outlook to 2.5% to 3.5%. Slower earnings growth could mean smaller dividend raises.
Realty Income: Monthly Checks With an A-Rated Balance Sheet Behind Them Realty Income (NYSE:O) is a real estate investment trust that owns over 15,500 properties. It rents them to 1,798 clients across 92 industries, mostly on long-term net rents where tenants cover taxes, insurance and maintenance. At $57.05, the stock yields 5.43%. That yield isn’t the result of a falling price, since the shares are roughly flat over the past year (down 0.05%).
Dividend safety: For a REIT, adjusted funds from operations (AFFO) is the right measure of coverage, because accounting depreciation makes GAAP earnings look smaller than the cash coming in. Second-quarter AFFO was $1.09 per share, against $0.8115 in dividends paid. That works out to a payout of about 74% of AFFO. The free cash flow yield of 7.18% sits above the dividend yield. The balance sheet has A-range credit ratings from all three major agencies: Moody’s A3, S&P A- and Fitch A. Net debt is 5.4x adjusted EBITDAre. Occupancy stands at 98.8%.
Track record: Realty Income has raised its dividend for 115 consecutive quarters and is part of to the S&P 500 Dividend Aristocrats index. Its dividend record shows a payment every month from 1999 onward, with the payout rising from $0.17 to $0.2715. The forward annual dividend is $3.258.
Bull case: Monthly payments match how retirees pay their bills. We rounded up seven of our favorite monthly payers in a free report here. The company keeps adding properties: it invested about $2.6B in the second quarter at a 7.3% initial cash yield. On re-leased properties, it recovered 102.7% of prior rent. A $6B hyperscale data center joint venture adds a new source of rent alongside retail and industrial.
Risk: Tenant credit quality. About 65.7% of annualized base rent comes from tenants without investment-grade ratings. A run of retail bankruptcies would put pressure on AFFO.
Verizon: The Biggest Yield in the Group, Covered Comfortably by Free Cash Flow Verizon (NYSE:VZ) provides wireless and broadband service to roughly 94.1 million postpaid phone connections and about 17.1 million broadband connections. The stock yields 6.18%, which puts it in ultra-high-yield territory. The yield is high even after a strong run: the shares are up 25.36% over the past year to $45.07. The stock trades at about 9x forward earnings.
Dividend safety: Free cash flow reached $6.43B in the second quarter, up 27.1% from a year earlier. The quarterly dividend of $0.7075 across 4,154,775,000 shares costs about $2.94 billion, roughly 46% of that quarter’s free cash flow. That leaves room for buybacks: Verizon had bought back $3.5B of stock through the second quarter. Net unsecured debt is 2.5x adjusted EBITDA.
Track record: Verizon’s quarterly payout has risen every year in its dividend history from $0.46 in 2009 to the current $0.7075. The forward annual dividend is $2.83.
The bull case: the core business is gaining strength. Verizon gained 184,000 postpaid phone customers, compared with a loss of 9,000 a year earlier. Postpaid phone churn, the share of customers who leave, improved to 0.92% from 0.97%. Adjusted EBITDA margin expanded to 40.1%. The Frontier Communications acquisition raised fiber connections to about 10.9M. Adjusted EPS of $1.30 beat the $1.27 estimate. Phone and internet bills get paid in any economy, and that is what funds this dividend.
Risk: Debt. Total unsecured debt stands at $136.5B. Leverage rose to 2.5x from 2.2x at the end of last year after the Frontier deal. Higher refinancing costs could reduce the cash available for dividend raises. Verizon appears on Barron’s list of stocks to watch this week. That makes its next quarterly update the first check on that leverage trend.
Income That Grows Alongside Your Benefit These three names suit retirees who want income from three different sources: everyday consumer brands, monthly rent checks and telecom bills. Realty Income offers the strongest coverage, with an A-rated balance sheet and monthly payments. Verizon has the highest yield and the largest free cash flow surplus. PepsiCo has the longest annual raise record in its dividend history, though its free cash flow covers the payout more narrowly than the other two. Together, they give a portfolio cash payouts that each business can fund, working alongside a Social Security check that rises with the COLA.
Contact [email protected] for any questions or corrections.
eBay ve výhledu na 3. čtvrtletí očekává tržby ve výši 3,07–3,12 mld. USD a non-GAAP EPS 1,36–1,42 USD; marže by měla kvůli Depopu klesnout na 25,1–25,6 %.
Key Takeaways eBay is set to report Q3 results on Oct. 28, with EPS estimated at $1.43 and revenues of $3.11 billion.Focused-category GMV surged 26% in Q2, while Depop is likely to add 1.5 points to eBay's Q3 revenue growth.eBay projects a 25.1-25.6% operating margin as Depop weighs on profits and organic GMV growth slows to 7-9%.
eBay (EBAY - Free Report) is scheduled to report its third-quarter 2026 results on Oct. 28, after market close.
For the third quarter, eBay expects total revenues between $3.07 billion and $3.12 billion. On an FX-neutral basis, year-over-year revenue growth is anticipated to be 8-10%. The Zacks Consensus Estimate for third-quarter 2026 revenues is pegged at $3.11 billion, suggesting 10.29% year-over-year growth.
eBay’s third-quarter 2026 non-GAAP earnings per share (EPS) are expected to be between $1.36 and $1.42. The consensus mark for earnings is pegged at $1.43 per share, up a penny over the past 30 and 60 days. The estimate implies 5.15% growth from earnings of $1.36 per share reported in the year-ago quarter.
eBay’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average positive surprise of 4.24%.
Let us see how things have shaped up for the upcoming announcement.
Factors Likely to Shape EBAY’s Q3 ResultseBay’s third-quarter 2026 results are expected to have benefited from strong momentum across its focused categories, including collectibles, Motors, fashion and refurbished goods. In the second quarter, focused-category gross merchandise volume (GMV) surged 26% year over year, accounting for more than 40% of total GMV. Sustained demand for trading cards, luxury fashion and automotive parts, coupled with expanded Authenticity Guarantee coverage and improved vehicle-fitment services, has strengthened buyer confidence. These initiatives are likely to have supported transaction volumes and revenue growth in the quarter under review.
eBay’s expanding consumer-to-consumer (C2C) and recommerce businesses, supported by the acquisition of Depop on July 30, are expected to have boosted third-quarter 2026 performance. Depop strengthens eBay’s presence in pre-loved fashion while expanding its reach among Gen Z and Millennial consumers. Core C2C GMV grew more than 20% in the second quarter, aided by AI-powered Magical Listing tools and improving seller engagement. Management expects Depop to contribute approximately 2.5 percentage points to consolidated FX-neutral GMV growth and 1.5 percentage points to revenue growth in the to-be-reported quarter.
eBay’s growing advertising business, complemented by expanding shipping and financial services capabilities, is expected to have strengthened third-quarter 2026 revenues. In the second quarter, first-party advertising revenues increased 24% year over year on an FX-neutral basis to $570 million, supported by stronger seller adoption and improved advertising relevance. Shipping revenues also recorded double-digit growth, reflecting increasing adoption of managed delivery solutions. Continued investments in Promoted Listings, cost-effective shipping and digital payment solutions are likely to have supported marketplace monetization and positively contributed to eBay’s take rate in the quarter under review.
However, eBay’s acquisition of Depop and increased investments in strategic growth initiatives are expected to have pressured third-quarter 2026 profitability. The company anticipates Depop to create a 3-4 percentage-point headwind to consolidated non-GAAP operating income growth and mid-single-digit dilution to non-GAAP earnings growth. Additionally, reduced interest income following the $1.4 billion cash acquisition is likely to have weighed on earnings. Management projects a non-GAAP operating margin of 25.1-25.6%, compared with 28.5% in the second quarter. These factors are expected to have constrained margin expansion and earnings growth in the to-be-reported quarter.
eBay’s third-quarter 2026 results are expected to have faced pressure from tougher year-over-year comparisons and slowing organic growth. The company indicated that the normalization of growth rates, which began in July, would affect third-quarter performance. Organic foreign exchange-neutral gross merchandise volume (GMV) growth is projected at 7-9%, compared with 14% in the second quarter. Moreover, persistent macroeconomic weakness in international markets and the strategic transition in Germany may have constrained marketplace activity. These factors are likely to have moderated eBay’s GMV and revenue growth in the quarter under review.
What Our Model Says About EBAY StockOur proven model predicts an earnings beat for eBay this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
eBay currently has an Earnings ESP of +0.20% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Other Stocks to ConsiderHere are some other companies worth considering, as our model shows that these too have the right combination of elements to beat earnings in their upcoming releases:
FIGS, Inc. (FIGS - Free Report) currently has an Earnings ESP of +5.00% and carries a Zacks Rank #2. FIGS’ shares have surged 77.8% year to date. FIGS is set to report its third-quarter 2026 results on Nov. 5. You can see the complete list of today’s Zacks #1 Rank stocks here.
Sweetgreen (SG - Free Report) presently has an Earnings ESP of +4.26% and a Zacks Rank #2. SG’s shares have gained 45.2% year to date. SG is set to report its third-quarter 2026 results on Nov. 5.
Murphy USA Inc. (MUSA - Free Report) has an Earnings ESP of +1.97% and a Zacks Rank #3 at present. MUSA’s shares have risen 32.4% year to date. MUSA is set to report its third-quarter 2026 results on Oct. 28.
Micron Technology Inc. (NASDAQ:MU) builds the memory chips inside AI servers. Its workers in Taoyuan, Taiwan, just sent a blunt message about who builds them.
Of 1,637 union members who voted on the company’s latest bonus offer, 1,633 rejected it, entrepreneur and independent analyst Shehroz Hussain wrote in his Tape Out newsletter.
The tally comes to 99.8% of ballots cast and, in Hussain’s words, "nearly 70% of the union’s membership."
The Taoyuan union confirmed the count in a statement on Sunday. "No" votes topped half of its entire membership, the union said, and first-day turnout beat its earlier strike vote.
MU stock is climbing. See the real-time price action here. What Workers Turned DownMicron plans quarterly performance-linked payments for employees worldwide starting in fiscal 2027, on top of its annual incentive program.
The pool is calculated as after-tax profit minus projected capital spending for the next quarter, using fiscal 2026 as the baseline. Half gets paid in cash after results, with the rest in shares vesting after one year.
Read Next
However, one number is missing. Unlike its South Korean rivals Samsung Electronics Co. Ltd. and SK Hynix Inc., Micron did not disclose a set share of earnings or the total amount reserved for employees, according to Reuters.
"The union still wants 15% of operating profit," Hussain wrote, referring to profit from the core business before interest and taxes.
"A strike has never been the goal, but a means of fighting for reasonable profit-sharing," the union said. It urged Micron not to use its 24-hour warning strike to "threaten and divide" workers.
Why the AI Boom Should CareTaiwan is a crucial production center for Micron’s DRAM and high-bandwidth memory (HBM) chips, both key components in AI servers. DRAM serves as a computer’s working memory, while HBM is a faster, stacked version mounted beside AI processors.
Micron employs about 15,000 people on the island, and its two unions together represent more than 80% of the Taiwan workforce. Labor action could amplify supply concerns in an already tight memory-chip market, according to Reuters.
Taipei is paying attention. Taiwan’s labor ministry urged Micron to consider workers’ concerns, put forward concrete proposals and negotiate with the union. On Oct. 15, President Lai Ching-te called on Micron and its workers to negotiate sincerely, Reuters reported.
Cracks in Taichung, TooManagement and the union at the larger Taichung facility signed an agreement on Wednesday, after which both sides withdrew from planned mediation. Reuters reported the terms were not made public.
Even so, the Taoyuan union says some Taichung members have launched a petition to withdraw their representatives’ authority. It has not disclosed how many signed.
The two sites are separate legal entities, so the Taichung deal does not cover Taoyuan. Talks there resume Oct. 27.
The Takeaway Hussain narrowed the story to one figure: "the percentage Micron eventually attaches to its profit pool, against the union’s 15% ask." In his view, "A number near that would show up in Micron’s Taiwan cost base."
MU Stock Price Activity: Micron stock was up 3.43% at $887.48 at the time of publication Monday, according to Benzinga Pro market data.
Read Next
Photo: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
MercadoLibre ve druhém čtvrtletí zvýšila hrubou hodnotu zboží (GMV) meziročně o 44 % na 21,9 mld. USD a počet aktivních kupujících o 26 % na 89,3 milionu.
Key Takeaways MercadoLibre's second-quarter GMV surged 44% to $21.9 billion, while active buyers rose 26% to 89.3 million.Brazil's lower shipping threshold fueled 39% FX-neutral GMV growth, while items sold jumped 56%.MELI's premium valuation, margin pressures and weaker demand in Mexico and Argentina cloud its growth outlook. MercadoLibre, Inc. (MELI - Free Report) continues to strengthen its position in Latin America's e-commerce market, supported by expanding buyer engagement, competitive pricing, and logistics investments. Its growing marketplace scale and efforts to improve the shopping experience are helping the company attract customers and deepen its presence across key markets.
The momentum was evident in second-quarter 2026 results, with gross merchandise volume (GMV) rising 44% year over year to $21.9 billion, or 36% on an FX-neutral basis. Items sold increased 45%, while unique active buyers climbed 26% to 89.3 million. Items purchased per buyer grew 14%, reflecting stronger engagement.
Brazil remains a key growth engine. The lower free-shipping threshold continued to support demand, with FX-neutral GMV increasing 39% and items sold rising 56%. Conversion improved 1.1 percentage points year over year. MercadoLibre also introduced buyer discounts for PIX payments and reduced seller take rates in selected categories, improving price competitiveness and helping active sellers grow 29%.
Broader product availability and faster delivery further reinforce its competitive position. Cross-border trade GMV increased 60% on an FX-neutral basis, while same-day and next-day shipments rose 38% to 225 million.
However, weaker consumer demand in Mexico and Argentina presents challenges to maintaining growth momentum. MercadoLibre's ability to sustain engagement, competitive pricing and service improvements will remain important to expanding its marketplace leadership.
How Does MercadoLibre Stack Up Against Its Industry?MercadoLibre, which competes with Amazon.com, Inc. (AMZN - Free Report) and Sea Limited (SE - Free Report) , has seen its shares decline 0.5% over the past three months against the industry’s 2.3% growth. While Amazon shares have climbed 7.2%, Sea Limited has fallen 28.5% in the aforementioned period.
Image Source: Zacks Investment Research
What Does MercadoLibre's Current Valuation Suggest?From a valuation standpoint, MercadoLibre's forward 12-month price-to-earnings (P/E) ratio is 34.75, higher than the industry average of 19.70. The stock is also trading above its 12-month median level of 34.29.
MercadoLibre is trading at a premium to Amazon (forward 12-month P/E of 22.53) and Sea Limited (14.54).
Image Source: Zacks Investment Research
What Do Earnings Estimates Signal for MercadoLibre?The Zacks Consensus Estimate for MercadoLibre’s current fiscal-year sales implies 44.5% year-over-year growth, while the consensus estimate for earnings per share suggests a 3.3% decline. For the next fiscal year, the consensus estimate indicates a 29% rise in sales and 44.9% growth in earnings.
Image Source: Zacks Investment Research
MELI’s Investment CaseMercadoLibre’s expanding marketplace presence, strong buyer engagement and integrated commerce-fintech ecosystem support its long-term growth potential. However, persistent margin pressures from strategic investments, softer consumer demand in key markets and a premium valuation remain concerns. Despite encouraging sales growth expectations, near-term earnings weakness and recent share-price underperformance suggest investors may prefer to remain cautious.
MELI currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Eli Lilly (LLY) vyplatí za čtvrté čtvrtletí 2026 dividendu ve výši 1,73 USD na akcii. Nárok na dividendu budou mít akcionáři zapsaní k 13. listopadu 2026; výplata proběhne 10. prosince 2026.
, /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2026 of $1.73 per share on outstanding common stock.
The dividend is payable on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For further discussion of risks and uncertainties relevant to Lilly's business that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
Refer to: Megan MacCauley; [email protected] (Media)
Michael Czapar; [email protected] (Investors)
Akcie Lockheed Martin v pondělí do 12:35 hodin ET vzrostly o 3,3 % poté, co tři analytici zvýšili své cílové ceny; Morgan Stanley nyní očekává cenu 835 USD.
Lockheed Martin (LMT +4.08%) stock just keeps flying higher.
Shares of the defense and aerospace giant jumped another 3.3% through 12:35 p.m. ET Monday after three separate Wall Street analysts chimed in with support for LockMart this morning. Let's take those in order:
Image source: Lockheed Martin.
Wall Street loves Lockheed Martin stockFirst up is Morgan Stanley analyst Kristine Liwag, who cites Lockheed's 10-year production contract with the Air Force to produce F-35 fighter jets at the rate of 156 aircraft per year as "reducing downside risk and providing visibility for its supply chain." At the same time, Liwag sees missile production boosting revenues in the mid-teens for the next five years.
Together, the analyst sees these developments pushing Lockheed stock up to $835 per share over the next year -- and deserving an upgrade to "overweight" (i.e., buy).
Bank of America and JP Morgan take a more cautious stance. Both kept their ratings on the defense giant at neutral today -- but raised their price targets regardless, to $620 per share and $665, respectively, as StreetInsider.com reports.
$628.85+$24.67 (+4.08%)
NYSE · As of 1:29 PM ET 10/26/26
What's next for Lockheed Martin stockOf the three, Bank of America analyst Ronald Epstein takes the most conservative position. Epstein likes the company's F-35 franchise and its larger contribution to Lockheed's revenues. He does worry, however, whether the increase in production at (presumably) bulk rates might depress Lockheed's profit margins?
That's a valid concern. Although aeronautics (the division that produces the F-35) is Lockheed's largest business, with $30.6 billion in annual revenue, it's already one of the company's less profitable divisions, generating operating profit margins below 7% last year. (The missiles division, in contrast, earned 13% margins!)
So more F-35 revenue could be a double-edged sword for Lockheed stock. Regardless, at a price-to-free cash flow ratio of less than 17x, a long-term earnings growth rate near 18%, and a dividend yield of 2.4%, Lockheed stock is cheap enough to be worth the risk.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lockheed Martin. The Motley Fool has a disclosure policy.
Key Takeaways RSG's Q3 revenues are projected to grow 4.7% y/y to $4.4B, while EPS is expected to reach $1.92.Collection revenues are expected to rise 6%, fueled by industrial activity, market-share gains and pricing.Landfill and transfer revenues are projected to grow 6.7%, aided by special waste and construction demand. Republic Services (RSG - Free Report) is scheduled to release third-quarter 2026 results on Oct. 29, after market close.
RSG has an impressive earnings surprise history. In the trailing four quarters, it surpassed the Zacks Consensus Estimate, with an average surprise of 5.5%.
Republic Services’ Q3 ExpectationsThe Zacks Consensus Estimate for the company’s revenues is set at $4.4 billion, implying a 4.7% increase from the year-ago quarter’s reported figure. The Zacks Consensus Estimate for the collection segment’s revenues is pegged at $3 billion, suggesting a year-over-year rise of 6%.
Robust industrial activity, accompanied by increased service requirements from large-container customers, is expected to have supported this segment’s growth. Strengthening manufacturing activity, market-share gains in the industrial and small-container business, and prudent pricing are expected to have provided additional support.
For Landfill revenues, the consensus estimate is $901.6 million, suggesting 6.7% year-over-year growth. Improving underlying demand for special waste is anticipated to have laid the foundation for this segment’s revenue growth.
The consensus estimate for transfer revenues is $503.6 million, implying a 6.7% year-over-year rally. Improving commercial construction and industry activity is expected to have raised waste movements, potentially solidifying transfer revenues.
For the environmental solutions segment, the Zacks Consensus Estimate for revenues is $461.6 million. It marks a 2.8% uptick from the year-ago quarter. Growing demand for per-and polyfluoroalkyl-related substances, including hazardous waste disposal, wastewater treatment, remediation and solid waste disposal, is expected to have benefited this segment.
The consensus estimate for revenues from the other segment is pegged at $211.2 million, suggesting 3.5% year-over-year growth.
The consensus estimate for earnings per share is pinned at $1.92, a slight step up from the year-ago quarter. Improved route efficiency, service execution and safety driven by the RISE digital platform and continued price discipline are factors expected to have supported the bottom line.
What Our Model Says About RSGOur proven model does not conclusively predict an earnings beat for Republic Services this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Republic Services has an Earnings ESP of -0.11% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are a few stocks from the broader Business Services sector, which, according to our model, have the right combination of elements to beat on earnings this time around.
Corpay (CPAY - Free Report) : The Zacks Consensus Estimate for the company’s third-quarter 2026 revenues is $1.4 billion, indicating 16.1% year-over-year growth. For earnings, the consensus estimate is pinned at $7.18 per share, suggesting a 26% gain from the year-ago quarter’s actual. The company beat the Zacks Consensus Estimate in the past four quarters, the average surprise being 3.6%.
CPAY has an Earnings ESP of +1.07% and a Zacks Rank of 3 at present.
The company is scheduled to announce third-quarter 2026 results on Oct. 4.
Casella Waste Systems (CWST - Free Report) : The Zacks Consensus Estimate for the company’s third-quarter 2026 revenues is $560.6 million, hinting at a 15.5% increase from the year-ago quarter’s actual. For earnings, the consensus estimate is pegged at 36 cents per share, suggesting a 14.3% decline from the year-ago quarter’s reported number. The company beat the Zacks Consensus Estimate in the past four quarters, the average surprise being 52.1%.
CWST has an Earnings ESP of +4.75% and a Zacks Rank of 3 at present. The company is scheduled to announce third-quarter 2026 results on Oct. 9.
Key Takeaways ITW expects Q3 revenues to rise 5% and adjusted EPS to increase 6.4%.Welding and Electronics revenues are projected to grow 9.5% and 10.1%, respectively.Weak construction markets, vehicle production and foreign currency headwinds may weigh on results.
Illinois Tool Works Inc. (ITW - Free Report) is scheduled to release third-quarter 2026 results on Oct. 27, 2026, before market open.
The Zacks Consensus Estimate for third-quarter earnings has remained steady in the past 30 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters. The average surprise was 2.9%.
The consensus estimate for third-quarter revenues is pegged at $4.26 billion, suggesting growth of 5% from the year-ago quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.99 per share, indicating a 6.4% increase from the year-ago quarter’s number.
Let’s see how things have shaped up for Illinois Tool this earnings season.
Factors to Note Ahead of ITW’s ResultsStrength in commercial construction in North America, along with positive contributions from residential renovation and improving demand across Europe and Australia/New Zealand, is likely to have boosted the performance of Illinois Tool’s Construction Products segment in the third quarter. Our model estimates the segment’s revenues to increase 1.1% year over year to $478.2 million.
Growth in medical, aerospace and consumer packaging markets is likely to have driven its Specialty Products segment’s performance. We expect the Specialty Products segment’s revenues to grow 2% year over year to $461.2 million.
Strong capital expenditure-related demand, broad-based growth across industrial and commercial markets, and healthy adoption of new products are expected to have aided the Welding segment’s performance in the third quarter. Our model estimates the segment’s revenues to increase 9.5% from the year-ago quarter to $522.1 million.
Strength in electronic assembly and semiconductor-related businesses, supported by expanded production capacity and differentiated product offerings, is expected to boost the Test & Measurement and Electronics segment’s results. We expect the segment’s revenues to increase 10.1% year over year to $768.3 million in the third quarter.
The Polymers & Fluids segment is anticipated to have performed well in the third quarter, driven by new product launches in the automotive aftermarket. We expect the segment’s revenues to increase 6.6% from the year-ago quarter to $$470.2 million.
However, weakness in the commercial and residential construction end markets, owing to lower demand for products in Europe, is likely to have hurt the Food Equipment segment’s revenues in the third quarter. The Automotive OEM segment’s performance is expected to have put up a weak show due to weak global vehicle production.
ITW has considerable exposure to overseas markets. Given the company’s substantial international operations, foreign currency headwinds are likely to have marred its profitability.
Earnings WhispersOur proven model does not conclusively predict an earnings beat for ITW this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: ITW has an Earnings ESP of -0.97% as the Most Accurate Estimate is pegged at $2.96 per share, which is lower than the Zacks Consensus Estimate of $2.99. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: Illinois Tool presently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Stanley Black & Decker, Inc. (SWK - Free Report) has an Earnings ESP of +1.10% and a Zacks Rank of 2 at present. The company is slated to release third-quarter 2026 results on Nov. 4.
Stanley Black’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 23.3%.
Deere & Company (DE - Free Report) has an Earnings ESP of +1.86% and a Zacks Rank of 3 at present. The company is slated to release third-quarter 2026 results on Nov. 25.
Deere & Company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, the average surprise being 11.1%.
Crane Company (CR - Free Report) has an Earnings ESP of +0.86% and a Zacks Rank of 3 at present. The company is scheduled to release third-quarter 2026 results on Oct. 27.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 10.4%.
Pembina Pipeline očekává, že EPS v roce 2026 vzroste o 15,79 % na 2,20 USD, přestože upravená EBITDA v segmentu potrubní přepravy meziročně klesla o 3 % na 626 mil. C$.
Key Takeaways Pembina Pipeline's shares gained 32.5% over 12 months, outperforming the sub-industry's 19% increase.2026 EPS is projected to grow 15.79%, supported by expansion projects and ethane agreements.Declining pipeline EBITDA, spread volatility and project execution risks challenge PBA's growth outlook.
Over the past 12 months, Pembina Pipeline Corporation (PBA - Free Report) stock has outperformed the Zacks Oil and Gas Production and Pipelines sub-industry. It gained 32.5% compared with the sub-industry's 19% increase. This reflects the stock's higher returns relative to its sub-industry over the past year.
12-Month Share-Price Performance Comparison
Image Source: Zacks Investment Research
Pembina Pipeline operates in the energy transportation and midstream services industry through three segments: Pipelines, Facilities, and Marketing and New Ventures. Its Pipelines segment has a transportation capacity of 2.9 million barrels of oil equivalent per day, supporting the movement of energy products across North America. The Facilities segment provides transportation and storage services for natural gas, condensate and natural gas liquids. Meanwhile, the Marketing and New Ventures segment focuses on buying and selling hydrocarbons, primarily sourced from the Western Canadian Sedimentary Basin.
Let's examine the key factors that could support Pembina Pipeline's growth and the risks that investors should consider before adding the stock to their portfolios.
Growth Drivers for Pembina Pipeline StockImproving Earnings Outlook: Pembina Pipeline’s earnings estimates indicate continued growth, with the Zacks Consensus Estimate for 2026 earnings per share pegged at $2.20. The estimate implies year-over-year growth of 15.79%, reflecting expectations for improved earnings performance in 2026.
Image Source: Zacks Investment Research
Integrated Asset Base: Pembina Pipeline connects natural gas, crude oil, condensate and natural gas liquids through processing, pipelines, storage, fractionation and export infrastructure. This integrated network can improve customer service and market access, while growth in one commodity stream may create additional throughput and service opportunities elsewhere.
Ambitious Growth Targets: Pembina Pipeline targets 5% to 7% annual growth in fee-based adjusted EBITDA per share through 2030. Its September presentation shows a path from C$6.76 per share at the midpoint of 2026 guidance to C$8.25-C$8.90 by 2030, supported by volume growth and sanctioned projects. Delivery depends on the stated project and volume assumptions
Stronger Ethane Supply Agreements: Pembina Pipeline sanctioned the C$570 million Heartland Extraction Plant and secured a long-term agreement to supply Dow with 22,500 barrels per day of ethane. Total contracted ethane volumes rise 15% to 57,500 barrels per day, while retained propane-plus output creates additional fractionation and marketing opportunities. This supports longer-term revenue visibility.
New Opportunity in Data Center Power: Pembina Pipeline and its partners reached a final investment decision on the 932-megawatt Greenlight gas-fired power facility for a Meta Platforms (META - Free Report) data center. Management expects a stable long-term cash-flow stream and stronger natural gas demand, with potential benefits for existing processing, transportation and natural gas liquids businesses. These benefits remain forward-looking.
Key Risks for Pembina Pipeline InvestorsDeclining Pipeline EBITDA: PBA’s pipeline adjusted EBITDA fell 3% year over year to C$626 million. The press release attributes part of the decline to the Alliance Pipeline’s new toll structure and revenue-sharing mechanism, which offset better contracted volumes and operating performance elsewhere in the pipeline division. This decline shows pressure on a major earnings segment.
Softer Q3 Outlook: PBA expects its third-quarter adjusted EBITDA contribution to be below the second quarter because of seasonal factors, spending timing and one-time items. Higher integrity and maintenance costs add pressure, so near-term results may weaken even though full-year guidance was reaffirmed. This creates a weaker near-term comparison.
Exposure to Market Volatility: PBA expects its U.S. and Canadian fractionation-spread businesses to represent about two-thirds of marketing in 2025-2026. It has hedged 90% of third-quarter exposure but only 40% of fourth-quarter exposure, leaving results more sensitive to spread movements later in the year. This leaves some marketing results exposed to spread volatility.
Potential Delays at Cedar LNG: PBA expects Cedar LNG to begin exports in late 2028, so the project will not contribute its full intended benefits immediately. Management identified the floating vessel’s final hookup and commissioning as the key remaining unknown, leaving timing and execution risk before operations start and cash flows ramp up materially.
Regulatory and Investment Hurdles: Pembina Pipeline’s proposed West Coast oil pipeline still needs regulatory approval, competitive cost estimates and sufficient volumes to support investment. Management said these conditions would be assessed over roughly 18 months, meaning the project’s potential benefits are not yet secured earnings and could delay investment approval.
Should Investors Buy or Hold PBA Stock?Pembina Pipeline’s earnings estimates point to continued growth, supported by its integrated asset base, long-term EBITDA per-share targets and expanded ethane supply agreement with Dow. The Greenlight gas-fired power facility also offers potential long-term cash flow opportunities. However, declining pipeline-adjusted EBITDA, a weaker near-term outlook and exposure to fractionation-spread volatility could pressure results. Delays and execution risks related to Cedar LNG and the proposed West Coast oil pipeline add further uncertainty to future growth. Given this mix of strengths and potential challenges, investors should wait for a more opportune entry point instead of adding this Zacks Rank #3 (Hold) stock to their portfolios.
On the other hand, META is a technology company that operates Facebook, Instagram, WhatsApp and Messenger while investing in artificial intelligence, digital advertising, and virtual and augmented reality technologies. META carries a Zacks Rank #3 at present.
Key PicksInvestors interested in the energy sector might consider some better-ranked stocks, such as Marathon Petroleum (MPC - Free Report) and Delek US Holdings (DK - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Marathon Petroleum is valued at $133.48 billion. The company is a leading U.S. independent refiner, marketer and transporter of petroleum products, with a strong refining footprint and an extensive midstream business. Marathon Petroleum benefits from its integrated operations, strategic refining assets and diversified earnings streams across the energy value chain.
Delek US Holdings is valued at $4.56 billion. It is a diversified downstream energy company engaged in petroleum refining, renewable fuels, asphalt production and logistics operations. Delek US Holdings operates multiple refineries in the United States and is committed to delivering safe, reliable energy while investing in cleaner energy initiatives.
Strategy drží 848 517 BTC v hodnotě 67,5 mld. USD a má 5,1 mld. USD v hotovosti, což jí umožní po dobu 3,4 roku pokrývat dividendy a úroky bez prodeje bitcoinů.
Strategy holds nearly $70 billion in Bitcoin while its stock slides and preferred dividends pile up, raising a question that could rattle crypto markets: how long before the company faces pressure to sell its prized holdings?
Strategy Inc. (NASDAQ: MSTR | MSTR Price Prediction) reported cash reserves of $5.1 billion, enough to cover dividends and interest payments for the next 3.4 years without selling any Bitcoin. Executive Chairman Michael Saylor shared on X on October 26, 2026, that the company holds 848,517 Bitcoin (CRYPTO: BTC), valued at about $67.5 billion, along with $5.1 billion in cash as of October 25.
Saylor announced, “Strategy has repurchased $205M of $STRC. As of 10/25/26, we hold 848,517 $BTC and $5.1B of USD Assets.” STRC refers to one of Strategy’s preferred stocks, which pays a fixed dividend to its holders before common shareholders receive any dividend.
Despite this promising news, investor reactions were mixed. On October 26, the value of Strategy’s shares fell by 5.8%, settling around $138. Meanwhile, Bitcoin is trading at $79,560 after Bitcoin ETFs posted their largest outflow since June, putting it about 37% below its record high of $126,080.
Saylor Outlines Cash Coverage for 3.4 Years of Payments
Saylor detailed that the cash reserve can cover its obligations for 3.4 years. Those obligations are large, as Strategy paid $400.7 million in preferred dividends in the second quarter alone, a figure that can escalate with each new stock issuance. He also noted that “USD Duration is 3.4 yrs and STRC’s BTC Credit is 54 bps assuming 10% BTC ARR, 40% BTC Vol, and a BTC price of $81,200.”
The USD Duration reflects how long the reserves can sustain dividend payments, while BTC Credit indicates how well Strategy’s Bitcoin assets safeguard STRC holders.
Strategy’s Bitcoin holdings remained unchanged from its October 19 filing, indicating no new Bitcoin purchases in the week leading up to October 25. The week before, the company bought 250 BTC, roughly $20 million at today’s prices, and repurchased $192 million of STRC shares. Saylor did not disclose details about cash reserves or annual dividend obligations.
Strategy’s Cash Reserve Has Grown Since Q2, but Its Bills Are Large
The company’s cash reserves have increased from $3.75 billion in Q2, enough to cover just over 2.1 years of payments. However, the company’s obligations are also significant. Its convertible debt totals $6.7 billion, and it posted a net loss of $8.22 billion in Q2, primarily from an $8.32 billion unrealized loss on its Bitcoin holdings, recorded when the price declines.
Has Strategy Sold Bitcoin This Year?
Strategy has a history of selling Bitcoin, having monetized $218.4 million through Q2, with board approvals for sales up to $1.25 billion to bolster cash reserves.
For a forced sale to occur, three factors must align: cash reserves must deplete, Bitcoin prices must drop significantly enough to challenge cash flow, and capital markets must close off funding opportunities. In Q2, capital markets were accessible, allowing Strategy to raise $8.41 billion through its at-the-market program, which involves gradually selling new shares.
Despite this, Strategy’s Bitcoin acquisitions have slowed as share buybacks took precedence, dropping from 250 BTC purchases to none within a week, while STRC share repurchases rose to $205 million. Strategy’s shares have fallen 51.7% over the past year, meaning each new share sale raises less money—diluting existing shareholders more.
Could Strategy Need to Sell Bitcoin Again?
At this point, a forced sale appears unlikely. With enough cash to cover 3.4 years, Strategy can maintain its dividend payments without needing to liquidate Bitcoin. However, a voluntary sale remains possible, given board approval and the company’s prior Bitcoin sales. For MSTR shareholders, not selling Bitcoin may require more share sales, which yield decreasing returns as the stock price continues to drop.
Strategy is anticipated to announce its Q3 results after the market closes on October 29. If the upcoming report shows Bitcoin sales exceeding the previously reported $218.4 million or USD Duration below 3.4 years, selling could increase further.
Contact [email protected] for any questions or corrections.
Key Takeaways GEN expects fiscal second-quarter 2027 revenues of $1.325-$1.350 billion and EPS of 71-73 cents.GEN blocked over 500 million scam attacks in Q1 as AI-enabled threats drive demand for protection.GEN's Engine Marketplace reached a $500 million revenue run rate and added over 30 partners in Q1. Gen Digital (GEN - Free Report) is scheduled to report second-quarter fiscal 2027 results on Oct. 28, after market close.
GEN expects non-GAAP revenues in the band of $1.325-$1.350 billion for the quarter. The Zacks Consensus Estimate for revenues is pegged at $1.33 billion, indicating 9.4% year-over-year growth.
For the fiscal second quarter, Gen Digital expects non-GAAP earnings in the range of 71-73 cents per share. The consensus mark for the same is pegged at 72 cents per share, suggesting a year-over-year rise of 16.1%. The estimate has remained unchanged over the past 30 days.
GEN’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.3%.
Factors to Note for GEN's Q2 EarningsGen Digital is expected to have gained from sustained demand for cybersecurity, identity protection and financial safety solutions due to the rapid rise in cyber threats, particularly AI-enabled scams. The emergence of cyber safety and financial wellness is likely to have been a tailwind for Gen Digital in the to-be-reported quarter.
In the Cyber Safety segment, rising concerns about AI-enabled scams are expected to have supported demand for Gen Digital's security and privacy solutions. The company's scam protection engine blocked more than 500 million scam attacks in the first quarter, while consumer research showed that more than 60% of respondents were more likely to pay for protection against AI-driven scams. Continued demand for higher-tier Norton 360 subscriptions, along with stronger cross-selling and upselling across Norton, Avast and Avira, is likely to have supported growth in the fiscal second quarter.
Engine Marketplace is expected to have supported revenue growth in the fiscal second quarter through the addition of partners, new product categories and broader distribution. The business reached an annual revenue run rate of approximately $500 million in the first quarter, added more than 30 partners and expanded into insurance. Further integration of Trellis insurance capabilities and partnerships with platforms such as Equifax could have helped connect GEN with more customers seeking financial products, which might have contributed significantly to the company's growth in the fiscal second quarter.
Momentum in the quarter is likely to have been supported by Gen Digital's expanding AI-driven product portfolio. Norton Neo, its AI-native browser, doubled its daily active users in the first quarter, while its Sage agent security engine was made available to 25 million customers through Norton 360 and Avast One. The launch of MoneyLion One, which combines financial wellness with identity and scam protection, is likely to have supported cross-selling opportunities in the fiscal second quarter.
What Our Model Says About GENOur proven model does not conclusively predict an earnings beat for GEN this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that’s not the case here.
GEN has an Earnings ESP of 0.00% and carries a Zacks Rank #2 at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With Favorable CombinationHere are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:
Seagate Technology (STX - Free Report) has an Earnings ESP of +2.07% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Seagate Technology is set to report first-quarter fiscal 2027 results on Oct. 27. The Zacks Consensus Estimate for Seagate Technology’s first-quarter fiscal 2027 earnings is pegged at $7.44 per share, up by 10 cents over the past seven days, indicating a rise of 185.1% from the year-ago quarter’s reported figure.
Amphenol (APH - Free Report) has an Earnings ESP of +1.72% and carries a Zacks Rank #2 at present.
Amphenol is set to report third-quarter 2026 results on Oct. 28. The Zacks Consensus Estimate for Amphenol’s third-quarter 2026 earnings is pegged at 73 cents per share, up by a penny over the past seven days, indicating a rise of 55.3% from the year-ago quarter’s reported figure.
Corning (GLW - Free Report) has an Earnings ESP of +0.34% and a Zacks Rank #2 at present.
Corning is slated to report third-quarter 2026 results on Oct. 27. The Zacks Consensus Estimate for Corning’s third-quarter 2026 earnings is pegged at 89 cents per share, up by a penny over the past seven days, indicating a rise of 32.8% from the year-ago quarter’s reported figure.
Proti společnosti FuelCell Energy byla podána hromadná žaloba kvůli údajným zavádějícím informacím; po oznámení ztráty ve výši 45,3 milionu USD akcie během jediné seance klesly téměř o 16 %.
, /PRNewswire/ -- National trial law firm Hagens Berman alerts investors in FuelCell Energy, Inc. (NASDAQ: FCEL) that a securities class action has been filed, and reminds investors that they have until November 10, 2026, to seek appointment as lead plaintiff.
If you purchased or acquired FuelCell securities during the Class Period and suffered significant financial losses, submit your losses now.
Key Details
Class Period: June 24, 2026 – Sept. 1, 2026Lead Plaintiff Deadline: Nov. 10, 2026Visit: www.hbsslaw.com/fcel Direct Contact Email: [email protected] Firm Telephone: 844-916-0895Video: https://youtu.be/GlhunVARgjoWhat is the FuelCell Securities Class Action About?
The lawsuit focuses on whether FuelCell Energy and certain top executives—including CEO Jason B. Few and CFO Michael S. Bishop—violated the Securities Exchange Act of 1934 by making materially false and misleading statements regarding the company's manufacturing capacity, production economics, and a major commercial agreement.
Specifically, the action alleges that throughout the Class Period, defendants touted a high-profile Capital Equipment Purchase Agreement (CEPA) announced on June 24, 2026, under which FuelCell agreed to supply carbonate fuel cell block systems for up to 380 megawatts (MW) of clean, baseload on-site power for data centers to Fit Energy USA LP (beginning with an initial 30 MW phase). Concurrently, FuelCell capitalized on the market enthusiasm by completing a massive underwritten public offering of over 12 million shares of common stock at $21 per share, raising roughly $245.5 million in net proceeds.
However, the complaint alleges that defendants failed to disclose critical operational realities to investors:
That FuelCell's actual manufacturing capacity was wholly inadequate to generate the production rates required under the Fit Energy CEPA;That the lagging production volume meant product costs and manufacturing overhead heavily exceeded the contractual pricing, locking the company into severe gross losses; andThat the company was tracking multi-million-dollar charges and inventory commitments tied to Phase 0 of the agreement that would decimate its quarterly profitability.The truth emerged before the market opened on September 2, 2026, when FuelCell reported its fiscal third-quarter 2026 financial results. The company revealed a staggering net loss of $45.3 million and a massive jump in gross losses—driven by $17 million in charges recorded for Phase 0 of the Fit Energy CEPA because current product costs and overhead exceeded contract pricing.
Following these disclosures, the price of FuelCell stock plummeted nearly 16% in a single trading session, severely damaging shareholders.
What Can FuelCell Investors Do?
If you purchased FCEL securities between June 24, 2026, and September 1, 2026, you may be eligible to participate in the lawsuit as a lead plaintiff.
The Private Securities Litigation Reform Act of 1995 permits any investor who suffered financial losses to seek appointment as lead plaintiff. You do not need to sell your shares to join the class action.
Click Here To Submit Your Losses Click Here to Discuss Your Legal Rights: Contact Hagens Berman attorneys to learn more about the case, the lead plaintiff timeline, and your options."We're focused on whether FuelCell may have misled investors about its manufacturing capabilities, as the suit alleges," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the claims in the pending suit.
Whistleblowers: Persons with non-public information regarding FuelCell should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Doporučení pro Vale bylo sníženo na „držet“ po celkovém zhodnocení 47 % od února 2025; navzdory rekordní produkci kovů rostou obavy z nákladů a závislosti na cenách železné rudy.
SummaryVale is downgraded to "Hold" after a strong 47% total return since February 2025, citing bearish technicals and valuation concerns.Despite record metals production and a 19% YoY EBITDA increase, VALE faces cost inflation and commodity price dependency, notably in iron ore.Shares now trade above their historical P/E, with a limited margin of safety; a normalized EPS of $1.80 and a 7x multiple suggest a fair value near $12.60.The technical breakdown below $13.50 signals further downside risk, with potential support at $11 and $9.50; earnings are a near-term catalyst. ribeirorocha/iStock via Getty Images
Vale (VALE) edged lower amid a Brazil bloodbath on Monday, October 26. The iShares MSCI Brazil ETF (EWZ) plunged 25%, its worst day in the fund's 26-year history. EWZ went from a 38% YTD gain in early October, following the
9.88K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Key Takeaways DHI faces housing demand pressure from high mortgage rates and affordability challenges.Sales incentives and pricing pressure weigh on profits, partly offset by lower construction costs.Backlog value is expected to rise from a year ago, even as net sales orders are projected to decline.
D.R. Horton Inc. (DHI - Free Report) is slated to report results for the fourth quarter of fiscal 2026 (ended Sept. 30) on Oct. 29, before the opening bell.
In the last quarter, the company’s earnings and revenues beat the Zacks Consensus Estimates by 7% and 0.5%, respectively. On a year-over-year basis, earnings declined 4.8%, while revenues increased marginally.
Markedly, D.R. Horton reported better-than-expected earnings in three of the trailing four quarters and missed on one occasion, the average surprise being 1.9%.
How Are Estimates Placed for D.R. Horton Stock?The Zacks Consensus Estimate for the quarter’s earnings per share (EPS) has been unchanged at $3.03 over the past 30 days. The estimated figure indicates a decline of 0.3% from the year-ago reported EPS of $3.04.
The consensus mark for revenues is $9.04 billion, indicating a 6.6% year-over-year decline.
Factors Likely to Shape DHI’s Q4 ResultsRevenuesD.R. Horton’s fourth-quarter fiscal 2026 revenues are expected to have declined year over year, reflecting continued pressure on housing demand and affordability. Elevated mortgage rates, higher homeownership costs and cautious consumer sentiment are likely to have weighed on home sales. The company expects sales incentives to have remained elevated during the quarter, with incentive levels depending on demand, mortgage rates and broader market conditions. These incentives might have helped support sales but could limit revenue growth.
Elevated sales incentives and affordability-focused pricing are also likely to have continued pressuring average selling prices (ASPs), limiting revenue growth despite its efforts to support demand. The company’s broad geographic footprint and focus on entry-level homes might have helped it respond to local market conditions, but affordability constraints remain a key challenge.
For the fourth quarter of fiscal 2026, D.R. Horton expects consolidated revenues of $8.8 billion to $9.3 billion and homebuilding closings of 22,500 to 23,000 homes. These targets reflect the company’s expectations under current market conditions. Affordability constraints and elevated incentives are likely to have remained key factors affecting performance.
Under the Homebuilding segment (which contributed 92% to the fiscal 2025 total revenues), the Zacks Consensus Estimate for DHI’s home sales is pegged at $8.26 billion for the fiscal fourth quarter, indicating a fall from the $8.54 billion reported a year ago. The consensus mark for the ASPs for homes delivered is expected to be $364,000.
Rental Property revenues (which contributed 4.8% to the total revenues in fiscal 2025) are expected to be $453 million, which implies a decline from the year-ago reported level of $805 million.
Conversely, Forestar revenues (which contributed 4.9% to the total revenues in fiscal 2025) are likely to be $624 million, which indicates a decline from the year-ago reported level of $671 million. The Financial Services segment’s revenues (which contributed 2.5% to the total revenues in fiscal 2025) are expected to be $212 million, which indicates a decline from the year-ago reported level of $218 million.
Margins & Bottom LineD.R. Horton’s earnings are expected to have declined year over year, with profitability likely to have remained under pressure from elevated sales incentives and pricing pressure. However, lower construction costs and improved construction efficiency might have partly offset these pressures. The company expects fiscal fourth-quarter home sales gross margin to range from 20.5% to 21%, indicating relatively stable margins sequentially.
Lower revenues and persistent pricing pressure are also likely to have weighed on operating leverage. Homebuilding SG&A expenses might have remained high relative to revenues if sales growth and average selling prices do not improve.
For the fiscal fourth quarter, D.R. Horton expects a consolidated pretax profit margin of 12.3% to 12.8%.
Orders & BacklogFor the fiscal fourth quarter, the consensus estimate suggests that net sales orders will decline 1% year over year to 19,874 units. The same for backlog is pegged at 13,095 units, which indicates 21.4% growth from that recorded a year ago. The value of the backlog is expected to be $5.02 billion, implying growth from the $4.12 billion reported a year ago.
What the Zacks Model Unveils for DHIOur proven model does not conclusively predict an earnings beat for D.R. Horton this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here.
Earnings ESP: DHI has an Earnings ESP of +0.15% at present. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank of 4 (Sell).
Stocks to ConsiderHere are some companies in the Zacks Construction sector, which, according to our model, have the right combination of elements to post an earnings beat.
Argan, Inc. (AGX - Free Report) has an Earnings ESP of +4.79% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
With the average surprise being 44.2%, Argan’s earnings beat estimates in each of the past four quarters. Argan’s is expected to register a 53.9% increase in earnings for the to-be-reported quarter.
Sterling Infrastructure, Inc. (STRL - Free Report) currently has an Earnings ESP of +0.80% and a Zacks Rank of 2.
With the average surprise being 27.2%, Sterling’s earnings beat estimates in each of the last four quarters. Sterling is expected to register a 74.4% increase in earnings for the to-be-reported quarter.
Quanta Services (PWR - Free Report) has an Earnings ESP of +2.66% and a Zacks Rank of 3.
With the average surprise being 17%, Quanta Services’ earnings beat estimates in each of the last four quarters. Quanta Services is expected to register a 50.5% increase in earnings for the to-be-reported quarter.
SummaryNasdaq remains a buy after strong earnings, with shares up over 4% since my last recommendation.NDAQ posted 14% revenue and ARR growth, robust enterprise license gains, and 20% YOY growth in Capital Access Platforms.Proprietary, walled-garden data positions NDAQ to benefit from AI-driven demand, despite rising competition and margin pressures.Debt remains elevated but is improving; I continue to monitor margins and macro risks, yet see NDAQ as attractively valued. hapabapa/iStock Editorial via Getty Images
I got the timing wrong when I assigned Nasdaq, Inc. (NDAQ) a buy back in late August. Days later, the stock tumbled, going from around $100 to below $90. Not the biggest drop, but still a drop. Yet the recent
1.48K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of NDAQ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
CME Group ve třetím čtvrtletí zvýšila průměrný denní objem obchodů o 16 % na rekordních 29,4 milionu kontraktů, zatímco mezinárodní objem vzrostl o 22 %.
Over the next few weeks, hundreds of companies will report quarterly results. If you own 20, 50, or 100 stocks, the reports can pile up faster than you can read them, and it's hard to know which ones deserve your time.
The last of six Rule Breakers Principles is built for this stretch: Review quarterly, manage accordingly.
A quarter gives a business enough time to show real change, whether that's a strong report or a sharp drop, without letting problems go unnoticed for long.
You don't need to give every stock the same attention.
Holdings that comprise about 5% of your portfolio deserve the full treatment, so read the earnings release, skim the conference call, and check what competitors are saying.Positions between about 1.5% and 5% usually need only a scan of the headlines that have occurred since your last check-in.Below 1.5%, it's fine to let a quarter slide. If any of those small positions turn into winners, they'll grow into bigger ones and earn more of your time.Let AI Do the First PassA short AI prompt can handle much of that headline scan. Here's one to adapt:
I'm doing a quarterly review of [company]. What are the most important developments from the past three months that a long-term shareholder should know? Compare the latest results with these reasons I bought it: [your reasons]. Keep it under 250 words and link to your sources.Asking for links is worth the extra words. AI tools can get facts wrong, so click through the primary sources before you act on anything.
Now try it on CME Group (CME +0.76%), which runs the world's leading derivatives marketplace and reported results on Oct. 21. When Team Rule Breakers recommended the company in Stock Advisor in June 2025, the case rested mainly on volatility driving trading volume, international trading growing faster than U.S. trading, and exceptionally high margins.
The third quarter backed up each point. Average daily volume rose 16% to a third-quarter record of 29.4 million contracts. International volume grew 22%. The operating margin was roughly 65%, in line with where it stood when the team recommended the stock. CME also returned nearly $1 billion to shareholders through dividends and buybacks.
For CME, managing accordingly means holding steady.
The case against holding starts with the share price. The team recommended CME at $270.59, and shares trade around $308 today. That's a solid gain, but the stock has trailed the S&P 500 since, even counting its dividend. Anyone hoping for a market beater has been disappointed so far.
A quarterly review, though, judges the business against the reasons you bought it. The team wanted a low-volatility stock that profits when markets turn turbulent, and this month has fit that description so far. While AI-linked stocks have slid, CME's shares have climbed more than 10%.
Holding CME makes sense if you believe markets will stay jumpy and that CME can keep its edge against European rivals. Team Rule Breakers still holds the stock and has recommended it again in other Motley Fool services since that recommendation last June.
Key Takeaways ICE's Exchange revenues are supported by trading volumes, new listings and customer growth. Fixed Income and Data Services and Mortgage Technology could gain from clearing activity & client expansions. Q3 ADV rose 31%, while higher technology investments and compensation costs are expected to lift expenses. Intercontinental Exchange Inc. (ICE - Free Report) is expected to register an improvement in both top and bottom lines when it reports third-quarter 2026 results on Oct. 29, before market open.
The Zacks Consensus Estimate for ICE’s third-quarter revenues is pegged at $2.73 billion, indicating 13.2% growth from the year-ago reported figure.
The consensus estimate for earnings is pegged at $1.97 per share. The Zacks Consensus Estimate for ICE’s third-quarter earnings has moved up 3.7% in the past 30 days. The estimate suggests a year-over-year increase of 15.2%.
What the Zacks Model Unveils for ICEOur proven model does not conclusively predict an earnings beat for Intercontinental Exchange this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). This is not the case, as you can see below.
Earnings ESP: Intercontinental Exchange has an Earnings ESP of -0.02%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: ICE carries a Zacks Rank #2 at present.
Factors Likely to Shape Q3 Results of ICEICE’s third-quarter results are likely to benefit from continued strength and consistency of business model, with growth across all three of its operating segments and strong free cash flow generation.
Fixed Income and Data Services revenues are likely to have gained from strength in fixed income data and analytics products and the data and network technology portfolio, and the CDS clearing business. Higher clearing volumes driven by elevated market volatility from geopolitical events, growth in the pricing and reference data business and strength in index business, growth in ICE Global Network offering, coupled with strength in consolidated feeds, desktop and derivative analytics revenues are expected to have supported the segment's performance. The Zacks Consensus Estimate for Fixed Income and Data Services revenues is pegged at $661 million.
Higher trading volumes in interest rate, energy and commodity futures and options markets, along with strong customer retention, new customer additions and increased spending by existing customers, new listings, higher net interest income and fees on collateral balances, are expected to have driven the Exchange segment. The Zacks Consensus Estimate for the Exchange segment revenues is pinned at $1.5 billion.
The Mortgage Technology segment is expected to benefit from higher origination volumes, revenue contributions from new client implementations and renewal expansions with existing customers that drove broader product adoption. Origination volume, renewal expansions of existing customers, MSP new client implementations, contractual price increases, renewal expansions and default management revenues, continued adoption of data solutions and increased purchases by existing customers are expected to have supported the segment's performance. The Zacks Consensus Estimate for the segment’s revenues is pegged at $551 million.
Expenses are likely to have increased owing to higher compensation and benefits, professional expenses, acquisition-related transaction costs, and technology and communication costs. Continued investments in AI capabilities, technology infrastructure and innovation initiatives are also expected to have elevated operating costs during the to-be-reported quarter.
For the third quarter of 2026, adjusted operating expenses are expected to be in the range of $1.063 billion to $1.073 billion.
ICE reported a 31% increase in third-quarter average daily volume (ADV). Total Agriculture & Metals ADV improved 57% year over year, while total Financials ADV increased 45% in the second quarter. Total Equity Indices ADV increased 12% year over year.
Stocks to ConsiderHere are some finance stocks you may want to consider, as our model shows that these, too, have the right combination of elements to post an earnings beat.
HCI Group, Inc. (HCI - Free Report) has an Earnings ESP of +4.10% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $5.01, indicating a year-over-year increase of 2.2%. You can see the complete list of today’s Zacks #1 Rank stocks here.
HCI’s earnings beat estimates in each of the last four reported quarters.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +5.25% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $7.03, indicating a year-over-year decrease of 37.1%.
ALL’s earnings beat estimates in each of the last four reported quarters.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +0.35% and sports a Zacks Rank of 3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $3.42 per share, implying an increase of 28.1% from the year-ago reported figure.
CBOE’s earnings beat estimates in each of the last four reported quarters.
Společnost Genmab povede klinickou studii fáze I/II kombinace přípravku INCB161734, petosemtamabu a chemoterapie u dosud neléčeného metastatického kolorektálního karcinomu s mutací KRAS G12D.
Key Takeaways Incyte and Genmab will test INCB161734, petosemtamab and chemotherapy in first-line KRAS G12D-mutated mCRC.Genmab will lead a phase I/II study, while Incyte supplies INCB161734 and shares development costs.Incyte is also evaluating INCB161734 in phase III pancreatic cancer and phase I solid tumor studies. Incyte Corporation (INCY - Free Report) has entered into a clinical trial collaboration with Denmark-based Genmab A/S (GMAB - Free Report) to evaluate a new combination therapy for the first-line treatment of patients with metastatic colorectal cancer (mCRC) carrying the KRAS G12D mutation.
The combination will include INCB161734, Incyte’s investigational KRAS G12D inhibitor, petosemtamab, Genmab’s investigational bispecific antibody and standard chemotherapy.
INCB161734 is an investigational, oral drug designed to selectively block the KRAS G12D mutation, which helps cancer cells grow and survive.
Petosemtamab is a bispecific antibody that targets two proteins, EGFR and LGR5, that play a role in cancer growth and the survival of cancer stem-like cells.
Combining these drugs with chemotherapy could offer a new treatment approach for patients with this type of colorectal cancer.
Under the agreement, Genmab will conduct a phase I/II clinical study evaluating the combination in patients with KRAS G12D-mutated mCRC who have not received prior treatment for their metastatic disease. Incyte will provide INCB161734 and share the development costs with Genmab.
KRAS mutations affect nearly 40% of colorectal cancers, with KRAS G12D being the most common KRAS mutation in this cancer type. According to the companies, the mutation is found in approximately 15% of colorectal cancer cases.
Year to date, Incyte shares have gained 17.1% compared with the industry’s 5.7% growth.
Image Source: Zacks Investment Research
Incyte Advances INCB161734 DevelopmentIncyte is evaluating INCB161734 across several clinical settings involving KRAS G12D-mutated cancers.
The candidate is being studied in the global phase III DAWN-303 study in previously untreated patients with KRAS G12D-mutated pancreatic ductal adenocarcinoma. The study is evaluating INCB161734 in combination with standard chemotherapy to assess its safety and efficacy.
INCB161734 is also being evaluated as a single agent and in combination with chemotherapy in an ongoing phase I study involving patients with KRAS G12D-mutated solid tumors.
More on Genmab’s PetosemtamabGenmab is developing petosemtamab for several solid tumors, including head and neck squamous cell carcinoma and colorectal cancer.
Petosemtamab is also being evaluated in two late-stage studies in combination with chemotherapy for first- and second-line treatment of RAS/BRAF wild-type metastatic colorectal cancer. The new collaboration with Incyte expands its clinical development into KRAS G12D-mutated mCRC, a distinct patient population.
INCY’s Zacks Rank & Stocks to ConsiderIncyte has a Zacks Rank #4 (Sell) at present.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the biotech sector are Halozyme Therapeutics (HALO - Free Report) and TG Therapeutics (TGTX - Free Report) , each sporting a Zacks Rank #1 at present.
Over the past 60 days, earnings per share estimates for Halozyme Therapeutics have increased from $8.37 to $8.80 for 2026. Over the same period, estimates for 2027 earnings per share have risen from $9.75 to $10.29. HALO’s shares have surged 86.7% year to date.
Halozyme Therapeutics’ earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the negative average surprise being 19.12%.
Over the past 60 days, earnings per share estimates for TG Therapeutics have risen from 92 cents to 94 cents for 2026. Over the same period, estimates for 2027 earnings per share have increased from $2.65 to $2.66. TGTX’s shares have risen 81.7% year to date.
TG Therapeutics’ earnings missed estimates in three of the trailing four quarters and beat in the remaining one, with the average surprise being 184.65%.
Neurocrine Biosciences očekává za čtvrtletí zisk na akcii (EPS) ve výši 2,57 USD, což představuje meziroční nárůst o 26 %, a výnosy ve výši 1,04 miliardy USD, meziročně vyšší o 31,1 %.
Neurocrine Biosciences (NBIX - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on November 2, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis biopharmaceutical company is expected to post quarterly earnings of $2.57 per share in its upcoming report, which represents a year-over-year change of +26%.
Revenues are expected to be $1.04 billion, up 31.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.21% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Neurocrine?For Neurocrine, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -4.23%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Neurocrine will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Neurocrine would post earnings of $2.26 per share when it actually produced earnings of $2.85, delivering a surprise of +26.11%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Neurocrine doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Společnost Williams Companies má ve čtvrtletí vykázat zisk na akcii (EPS) ve výši 0,56 USD, což představuje meziroční nárůst o 14,3 %, a tržby ve výši 3,19 miliardy USD, meziročně vyšší o 9 %.
The market expects Williams Companies, Inc. (The) (WMB - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on November 2, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis pipeline operator is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of +14.3%.
Revenues are expected to be $3.19 billion, up 9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.02% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for The Williams Companies?For The Williams Companies, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.65%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that The Williams Companies will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that The Williams Companies would post earnings of $0.52 per share when it actually produced earnings of $0.50, delivering a surprise of -3.85%.
Over the last four quarters, the company has beaten consensus EPS estimates just once.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
The Williams Companies appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Společnost Weyerhaeuser má ve 3. čtvrtletí 2026 vykázat zisk na akcii (EPS) ve výši 5 centů, oproti 6 centům ve stejném období předchozího roku, přestože tržby mají vzrůst o 6,3 % na 1,83 miliardy USD.
Key Takeaways WY's Wood Products segment may benefit from higher lumber volumes, realizations and EWP price adjustments.Timberlands faces pressure from lower sales realizations and reduced Japan shipments due to vessel timing.Higher fuel, resin and manufacturing costs may weigh on earnings, partly offset by lower lumber costs. Weyerhaeuser Company (WY - Free Report) is slated to report third-quarter 2026 results on Oct. 29, after the closing bell.
In the last reported quarter, Weyerhaeuser’s adjusted earnings topped the Zacks Consensus Estimate by 116.7%, while net sales surpassed the same by 4%. Meanwhile, on a year-over-year basis, adjusted earnings increased, but net sales declined. The company reported adjusted earnings of 13 cents per share, up 8.3% from 12 cents in the year-ago period. Net sales of $1.87 billion decreased 0.9% from the $1.89 billion reported in the year-ago quarter.
Weyerhaeuser’s earnings beat the consensus mark in each of the past four quarters, with the average surprise being 127%.
How Are Estimates Placed for Weyerhaeuser Stock?The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) has decreased to 5 cents from 8 cents over the past 30 days. In the year-ago quarter, the company reported an EPS of 6 cents.
The consensus mark for net sales is pegged at $1.83 billion, indicating a 6.3% year-over-year rise.
Factors Influencing WY’s Q3 ResultsRevenuesWeyerhaeuser’s third-quarter 2026 revenues are expected to have increased year over year, supported by anticipated growth in Wood Products sales volumes and higher lumber realizations. However, performance is likely to have varied across segments, reflecting differences in product pricing, demand and transaction timing.
Within Wood Products, which accounted for approximately 72.8% of second-quarter 2026 net sales, higher lumber production and sales volumes are expected to have supported revenues. Higher lumber realizations and planned engineered wood products (“EWP”) price adjustments might have provided additional support. However, OSB realizations are expected to have remained under pressure from supply exceeding demand. Our model predicts the Wood Products segment’s net sales to increase 11.1% year over year to $1.36 billion in the third quarter.
Timberlands, which accounted for approximately 27.7% of second-quarter 2026 net sales, is likely to have faced pressure from lower average domestic sales realizations due to product mix in the West and lower sales realizations in the North. Lower sales volumes to Japan due to vessel timing might have also weighed on revenues. Our model predicts the Timberlands segment’s net sales to decline 3% to $519.9 million.
For Strategic Land Solutions (formerly Real Estate, Energy & Natural Resources), which accounted for approximately 7.5% of second-quarter 2026 net sales, revenue performance is likely to have depended on the timing and mix of real estate transactions and activity across its businesses. Our model predicts the segment’s net sales to be $100.6 million, down 2.3% year over year.
EarningsWeyerhaeuser’s third-quarter 2026 earnings are expected to have declined year over year, as higher fuel and manufacturing costs in Wood Products are likely to have offset some benefits from improved sales volumes and pricing. The company expects Timberlands earnings and adjusted EBITDA to be slightly higher than second-quarter levels, while Strategic Land Solutions earnings and adjusted EBITDA are expected to decline approximately $30 million and $45 million, respectively, due primarily to the timing and mix of real estate sales.
Our model predicts Timberlands’ adjusted EBITDA to decline 13.3% from a year ago to $128.3 million. For Strategic Land Solutions, adjusted EBITDA is expected to decline 11.4% from a year ago to $80.6 million.
Within Wood Products, the company expects third-quarter earnings and adjusted EBITDA to be moderately lower sequentially by approximately $30 million, excluding changes in average sales realizations for lumber and oriented strand board (“OSB”). Higher-than-expected fuel costs and an unfavorable mix shift in EWP are the primary reasons for the revised outlook.
Our model predicts Wood Products adjusted EBITDA to grow year over year to $102.5 million in the third quarter. Higher fuel costs, planned OSB maintenance and increased resin costs are expected to have pressured margins, while slightly lower lumber unit manufacturing costs might have partly offset these pressures.
What Our Model Unveils for WY StockOur proven model does not predict an earnings beat for Weyerhaeuser this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here.
Earnings ESP: WY has an Earnings ESP of -34.78%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank #4 (Sell).
Stocks to ConsiderHere are some stocks from the Zacks Construction sector, which, per our model, have the right combination of elements to deliver an earnings beat this time around.
Argan, Inc. (AGX - Free Report) has an Earnings ESP of +4.79% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
With the average surprise being 44.2%, Argan’s earnings beat estimates in each of the past four quarters. Argan’s is expected to register a 53.9% increase in earnings for the to-be-reported quarter.
Sterling Infrastructure, Inc. (STRL - Free Report) currently has an Earnings ESP of +0.80% and a Zacks Rank of 2.
With the average surprise being 27.2%, Sterling’s earnings beat estimates in each of the last four quarters. Sterling is expected to register a 74.4% increase in earnings for the to-be-reported quarter.
Quanta Services (PWR - Free Report) has an Earnings ESP of +2.66% and a Zacks Rank of 3.
With the average surprise being 17%, Quanta Services’ earnings beat estimates in each of the last four quarters. Quanta Services is expected to register a 50.5% increase in earnings for the to-be-reported quarter.
Willis Towers Watson má ve 3. čtvrtletí 2026 vykázat tržby ve výši 2,48 miliardy USD, což představuje meziroční nárůst o 8,3 %, a zisk na akcii ve výši 3,60 USD.
Key Takeaways Health revenues are expected to benefit from growth across regions, while Wealth gains from retirement work. CRB could benefit from new business and client retention, while technology software sales support ICT. Expenses are expected to reach $2 billion, driven by higher salaries and interest expense. Willis Towers Watson Public Limited Company (WTW - Free Report) is expected to register an improvement in both top and bottom lines when it reports third-quarter 2026 results on Oct. 29, before the opening bell.
The Zacks Consensus Estimate for WTW’s third-quarter revenues is pegged at $2.48 billion, indicating an 8.3% increase from the year-ago reported figure.
The consensus estimate for earnings is pegged at $3.60 per share. The Zacks Consensus Estimate for WTW’s third-quarter earnings has moved south by 0.3% in the past 30 days. The estimate suggests a year-over-year increase of 17.3%.
What the Zacks Model UnveilsOur proven model does not conclusively predict an earnings beat for Willis Towers this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). This is not the case, as you can see below.
Earnings ESP: Willis Towers has an Earnings ESP of +2.33%. This is because the Most Accurate Estimate of $3.68 is pegged higher than the Zacks Consensus Estimate of $3.60. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Willis Towers carries a Zacks Rank of 4 (Sell) at present.
Factors Likely to Shape Q3 Results of WTWRevenues in the third quarter are likely to have benefited from strong performances across the segments.
Growth across all regions, with International leading the overall performance, is likely to have aided organic revenue growth in Health in the to-be-reported quarter.
Wealth business revenues are likely to have benefited from higher levels of retirement work across all regions.
Career revenues are likely to have been affected by increased levels of communications project work and broad-based pay work, which were likely to be offset by constrained revenues in the Middle East due to the ongoing conflict.
The Benefits Delivery & Outsourcing segment’s performance is expected to have benefited from expanded project work, new client wins and regulatory-driven work in Outsourcing. The upside is likely to be partially offset by lower commissions in Individual Marketplace.
Corporate Risk & Broking is expected to have benefited from new business activity and strong client retention globally.
Insurance Consulting and Technology is expected to have benefited from strong software sales in the Technology practice.
Expenses in the third quarter are likely to have increased, attributable to higher salary expense, higher professional services costs, increased local office expenses, a higher depreciable base of assets, and higher interest expense. We expect the metric to be $2 billion in the to-be-reported quarter.
Stocks to ConsiderSome insurance stocks with the right combination of elements to come up with an earnings beat this time around are:
HCI Group, Inc. (HCI - Free Report) has an Earnings ESP of +4.10% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $5.01, indicating a year-over-year increase of 2.2%. You can see the complete list of today’s Zacks #1 Rank stocks here.
HCI’s earnings beat estimates in each of the last four reported quarters.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +5.25% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $7.03, indicating a year-over-year decrease of 37.1%.
ALL’s earnings beat estimates in each of the last four reported quarters.
MetLife, Inc. (MET - Free Report) has an Earnings ESP of +0.59% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for third-quarter 2026 earnings is pegged at $2.71, indicating a year-over-year increase of 15.8%.
MET’s earnings beat estimates in each of the last four reported quarters.
Společnost Xylem má ve třetím čtvrtletí vykázat tržby ve výši 2,28 miliardy USD, což představuje meziroční nárůst o 0,4 %, a zisk na akcii ve výši 1,47 USD, meziročně vyšší o 7,3 %.
Key Takeaways XYL's Q3 earnings are expected to grow 7.3% year over year, while revenues are projected to increase 0.4%.Strong infrastructure demand, data-center growth and the TriOS buyout are likely to support XYL's revenues.XYL's negative Earnings ESP of -1.27%, project delays and rising costs cloud its Q3 earnings outlook.
Xylem Inc. (XYL - Free Report) is scheduled to release third-quarter 2026 results on Oct. 27, before market open.
The Zacks Consensus Estimate for XYL’s third-quarter revenues is pegged at $2.28 billion, indicating growth of 0.4% from the prior-year quarter’s number. The consensus mark for earnings is pinned at $1.47 per share, which has been stable in the past 60 days. The figure indicates an increase of 7.3% from the year-ago quarter’s figure.
The company’s earnings surpassed the Zacks Consensus Estimate thrice in the trailing four quarters and matched the mark in one, the average surprise being 5.6%.
Let’s see how things have shaped up for Xylem this earnings season.
Factors Likely to Have Shaped XYL’s Quarterly PerformanceStrength in the transport application business, aided by increased infrastructure projects in the United States, is likely to have supported the Water Infrastructure segment’s performance. However, weakness in the water treatment business and lower demand in China are likely to have been a spoilsport. The Zacks Consensus Estimate for the Water Infrastructure segment’s revenues is pegged at $668 million, indicating 1.8% growth from the year-ago figure.
Electric metering project delays are expected to have affected the performance of the Measurement & Control Solutions (M&CS) segment in the third quarter. However, growing popularity for the company’s advanced metering solutions is likely to have offered some respite. The Zacks Consensus Estimate for the M&CS segment’s revenues is pinned at $486 million, reflecting a 6.9% decline from the year-ago quarter’s figure.
Strength in the Applied Water segment, supported by higher demand in commercial building and data-center markets, is likely to augment the segment’s results. The Zacks Consensus Estimate for the Applied Water segment’s revenues is pegged at $469 million, indicating 2.9% growth from the year-ago figure.
Recovery in Xylem’s dewatering applications business across utility and power end markets is likely to augment the Water Solutions and Services segment’s results. The Zacks Consensus Estimate for the Water Solutions and Services segment’s revenues is pegged at $671 million, indicating 5.8% growth year over year.
XYL’s acquisition of TriOS (in July 2026) added optical sensing and water-quality monitoring technology to the M&CS segment. This buyout is expected to bolster the company’s top-line results in the to-be-reported quarter.
However, XYL’s bottom line is likely to have reflected the impact of inflationary pressures in the third quarter. Also, increased spending on strategic investments is expected to have hurt its margins.
Earnings WhisperOur proven model does not conclusively predict an earnings beat for Xylem this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: Xylem has an Earnings ESP of -1.27% as the Most Accurate Estimate is pegged at $1.45 per share, which is lower than the Zacks Consensus Estimate of $1.47. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: XYL presently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Emerson Electric Co. (EMR - Free Report) has an Earnings ESP of +0.40% and a Zacks Rank of 2 at present. The company is scheduled to release fourth-quarter fiscal 2026 results on Nov. 4.
Emerson’s earnings beat the Zacks Consensus Estimate twice and matched on the other two occasions of the preceding four quarters, the average surprise being 1.3%.
Constellium (CSTM - Free Report) has an Earnings ESP of +14.50% and a Zacks Rank of 2 at present. The company is slated to release second-quarter 2026 results on Oct. 28.
Constellium’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 83.3%.
Kennametal Inc. (KMT - Free Report) has an Earnings ESP of +1.50% and a Zacks Rank of 3 at present. The company is slated to release first-quarter fiscal 2027 results on Nov. 4.
Kennametal’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 29.3%.
Společnost Otis Worldwide má ve 3. čtvrtletí vykázat tržby ve výši 3,85 miliardy USD, což představuje meziroční růst o 4,3 %, zatímco zisk na akcii (EPS) by měl klesnout o 4,8 % na 1 USD.
Key Takeaways Otis Worldwide's Q3 sales are projected to rise 4.3% to $3.85 billion, while EPS may fall 4.8% to $1.Repair and modernization demand may lift Service sales 5.3%, while New Equipment sales may fall 1.2%.Labor and material costs may push Service and New Equipment operating margins down 60 and 160 bps.
Otis Worldwide Corporation (OTIS - Free Report) is scheduled to report third-quarter 2026 results on Oct. 28, before the opening bell.
In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 1%, and net sales topped it by 3.7%. On a year-over-year basis, the bottom line declined 3.8%, while the top line grew 7.3%.
OTIS’ earnings surpassed the consensus mark in two of the trailing four quarters, missed on one occasion and met on the remaining occasion, with an average surprise of 1%.
How Are Estimates Placed for OTIS Stock?For the third quarter, the Zacks Consensus Estimate for earnings per share (EPS) has trended downward to $1 from 99 cents in the past 30 days. The estimated figure indicates a 4.8% decline from the year-ago adjusted EPS of $1.05.
The consensus mark for net sales is pegged at $3.85 billion, indicating 4.3% growth from the year-ago figure of $3.7 billion.
Key Factors to Note for OTIS’ Q3 EarningsSales
Otis Worldwide’s third-quarter performance is likely to have benefited from continued momentum in its Service segment, which accounted for 66.9% of second-quarter 2026 net sales. Strong repair and modernization demand, along with improving maintenance trends, is expected to have kept the segment a primary growth driver. Management projects mid-single-digit growth in Service organic sales for the third quarter, supported by repair and modernization activity, although modernization growth is expected to have moderated sequentially. The company’s focus on service quality, pricing initiatives and backlog execution is also likely to have supported revenue growth in the to-be-reported quarter.
Maintenance and repair initiatives are also likely to have supported performance. Otis Worldwide continues to implement value-driven micro-pricing strategies and proactive repair offerings to strengthen customer engagement and improve pricing realization. The company previously outlined approximately $35 million in incremental repair pricing benefits for 2026. These initiatives, alongside higher repair volumes, are expected to have supported third-quarter Service performance.
The company’s Service Excellence and digital initiatives are likely to have aided operational execution. Otis Worldwide has been investing in service quality, field productivity and customer retention, supported by AI-assisted tools and standardized operating processes. Continued implementation of these initiatives, along with its broader Service Operating Model, is likely to have strengthened customer service and execution capabilities in the quarter under review.
However, weakness in the New Equipment segment, which accounted for 33.1% of second-quarter 2026 net sales, is likely to have partly constrained third-quarter top-line growth. Although management expects sales trends to improve sequentially, subdued construction activity and pricing pressure in China, alongside demand challenges in the Middle East and Southern Europe, are likely to have weighed on the segment’s performance.
For the third quarter, our Zacks model predicts the Service segment’s net sales to increase year over year by 5.3% to $2.56 billion, with the New Equipment segment’s net sales declining 1.2% to $1.24 billion.
Margins
On the margin front, higher labor and material costs, productivity challenges and ongoing Service investments are expected to have remained headwinds. Longer onboarding periods for skilled mechanics and higher labor rates associated with accelerating repair and modernization execution are likely to have continued affecting profitability in the to-be-reported quarter. We expect the adjusted operating margin in the Service and New Equipment segments to contract 60 basis points (bps) and 160 bps year over year to 24% and 3.1%, respectively.
Moreover, delayed improvements in maintenance customer retention and a measured approach to incremental micro-pricing are expected to have limited margin recovery. Management previously identified approximately $20 million in retention and maintenance pricing-related headwinds and an additional $50 million in productivity and field-cost pressures relative to its earlier full-year outlook. For the to-be-reported quarter, our model expects SG&A expenses to increase year over year by 2.8% to $518.3 million. Although higher repair pricing, modernization volumes and cost-reduction initiatives are expected to have provided some support, these benefits may have been partly offset by continued operating cost pressures.
What Our Model Unveils for OTISOur proven model does not predict an earnings beat for Otis Worldwide this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, it is not the case here.
OTIS’ Earnings ESP: The company has an Earnings ESP of -0.57%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
OTIS’ Zacks Rank: Currently, the stock carries a Zacks Rank #3.
Stocks With the Favorable CombinationHere are some companies from the Industrial Products sector, which, according to our model, have the right combination of elements to post an earnings beat in their respective quarters to be reported.
Eaton Corporation plc (ETN - Free Report) has an Earnings ESP of +0.45% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Eaton’s earnings topped the consensus mark in three of the last four quarters and met on the remaining occasion, with the average surprise being 1.3%. Earnings for ETN’s third quarter of 2026 are expected to grow 15% year over year.
Kennametal Inc. (KMT - Free Report) currently has an Earnings ESP of +1.50% and a Zacks Rank of 3.
Kennametal’s earnings topped the consensus mark in each of the last four quarters, with the average surprise being 29.3%. Earnings for KMT’s third quarter of 2026 are expected to surge a whopping 682.4% year over year.
Watsco, Inc. (WSO - Free Report) has an Earnings ESP of +0.46% and a Zacks Rank of 3 at present.
Watsco’s earnings topped the consensus mark in one of the last four quarters and missed on the remaining three occasions, with the average negative surprise being 4.9%. Earnings for WSO’s third quarter of 2026 are expected to improve 3.8% year over year.
CNA Financial očekává za čtvrtletí končící v září 2026 zisk 1,16 USD na akcii, což představuje meziroční pokles o 22,7 %, při tržbách ve výši 3,54 mld. USD (+3,1 %).
The market expects CNA Financial (CNA - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 2. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis insurance holding company is expected to post quarterly earnings of $1.16 per share in its upcoming report, which represents a year-over-year change of -22.7%.
Revenues are expected to be $3.54 billion, up 3.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for CNA Financial?For CNA Financial, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -2.59%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that CNA Financial will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that CNA Financial would post earnings of $1.04 per share when it actually produced earnings of $1.19, delivering a surprise of +14.42%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
CNA Financial doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAnother stock from the Zacks Insurance - Property and Casualty industry, Hanover Insurance Group (THG - Free Report) , is soon expected to post earnings of $4.47 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -12.2%. Revenues for the quarter are expected to be $1.74 billion, up 3.8% from the year-ago quarter.
The consensus EPS estimate for Hanover Insurance has remained unchanged over the last 30 days. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +6.83%.
When combined with a Zacks Rank of #2 (Buy), this Earnings ESP indicates that Hanover Insurance will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
IDEX má ve 3. čtvrtletí 2026 vykázat upravený zisk ve výši 2,23 USD na akcii, což představuje meziroční nárůst o 9,9 %, při tržbách ve výši 919,4 milionu USD.
Key Takeaways IDEX expects Q3 2026 adjusted EPS to rise 9.9% and revenues to grow 4.6%.Health & Science Technologies revenues are projected to grow 11% on strong end-market demand.Acquisitions and water demand may aid growth, while dispensing weakness and rising costs pose risks. IDEX Corporation (IEX - Free Report) is scheduled to release third-quarter 2026 results on Oct. 28, before market open.
The Zacks Consensus Estimate for third-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 7.7%.
The consensus estimate for revenues is pegged at $919.4 million, indicating an increase of 4.6% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.23 per share, indicating an increase of 9.9% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s ResultsThe Health & Science Technologies (HST) segment is expected to have benefited from strength in the data center, semiconductor, space and defense markets in the third quarter. The consensus estimate for the HST segment’s revenues is pegged at $423 million, indicating an increase of 11% year over year.
An increase in demand for products across the municipal water end market is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher demand for mining application solutions business is likely to have been a tailwind as well. The consensus estimate for the FMT segment’s revenues is pegged at $321 million, indicating growth of 1.3% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technology offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets. However, positive pricing is expected to have provided some relief. The consensus estimate for the segment’s revenues is pegged at $182 million, matching the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
Earnings WhisperOur proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of 0.00% as both the Zacks Consensus Estimate and the Most Accurate Estimate are pegged at $2.10 per share. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank of 3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Stanley Black & Decker, Inc. (SWK - Free Report) has an Earnings ESP of +1.10% and a Zacks Rank of 2 at present. The company is slated to release third-quarter 2026 results on Nov. 4.
Stanley Black’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 23.3%.
Deere & Company (DE - Free Report) has an Earnings ESP of +1.86% and a Zacks Rank of 3 at present. The company is slated to release third-quarter 2026 results on Nov. 25.
Deere & Company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, the average surprise being 11.1%.
Crane Company (CR - Free Report) has an Earnings ESP of +0.86% and a Zacks Rank of 3 at present. The company is scheduled to release third-quarter 2026 results on Oct. 27.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 10.4%.
BWX Technologies očekává za čtvrtletí EPS ve výši 1,19 USD, což představuje meziroční nárůst o 19 %, při tržbách 992,35 milionu USD (+14,6 %). Ukazatel Earnings ESP činí +0,22 %.
The market expects BWX Technologies (BWXT - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 2. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis supplier of nuclear fuel and components to the U.S. government is expected to post quarterly earnings of $1.19 per share in its upcoming report, which represents a year-over-year change of +19%.
Revenues are expected to be $992.35 million, up 14.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.06% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for BWX?For BWX, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.22%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that BWX will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that BWX would post earnings of $1.01 per share when it actually produced earnings of $1.07, delivering a surprise of +5.94%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
BWX appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Aerospace - Defense Equipment industry, ATI (ATI - Free Report) , is soon expected to post earnings of $1.36 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +60%. This quarter's revenue is expected to be $1.32 billion, up 17.4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for ATI has been revised 1.1% up to the current level. Nevertheless, the company now has an Earnings ESP of +1.09%, reflecting a higher Most Accurate Estimate.
When combined with a Zacks Rank of #1 (Strong Buy), this Earnings ESP indicates that ATI will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Opce na Hub Group se splatností 16. dubna 2027 a realizační cenou 17,50 USD vykazují mimořádně vysokou implikovanou volatilitu, což signalizuje očekávání výrazného pohybu ceny akcií.
Investors in Hub Group, Inc. (HUBG - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the April 16, 2027 $17.50 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Hub Group, but what is the fundamental picture for the company? Currently, Hub Group is a Zacks Rank #5 (Strong Sell) in Transportation - Services Industry that ranks in the Bottom 23% of our Zacks Industry Rank. Over the last 60 days, no analyst has increased his estimate for the current quarter, while two have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter to move from 55 cents per share to 26 cents per share in the same time period.
Given the way analysts feel about Hub Group right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
International Paper očekává ve třetím čtvrtletí upravenou EBITDA z pokračujících činností ve výši 780 až 830 milionů USD, což představuje meziroční pokles o 6 %.
Key Takeaways International Paper expects Q3 adjusted EBITDA from continuing operations of $780-$830 million.Lower maintenance costs, pricing gains and 80/20 initiatives may offset high transportation and energy costs.Packaging Solutions EMEA EBITDA is projected to rise 37% sequentially and North America expected to gain 33%. International Paper Company (IP - Free Report) is scheduled to report third-quarter 2026 results on Oct. 28, 2026, before the opening bell.
The Zacks Consensus Estimate for IP’s second-quarter revenues is pegged at $6.35 billion, indicating a 2% increase from the year-ago reported figure.
The consensus estimate for International Paper’s earnings has moved down 9% to 30 cents per share. Despite the revision, it suggests an improved performance from the loss of 43 cents per share in the year-ago quarter.
Image Source: Zacks Investment Research
IP’s Earnings Surprise HistoryInternational Paper’s earnings missed the Zacks Consensus Estimate in three of the trailing four quarters, while surpassing in one quarter, the average surprise being negative 31.6%.
Image Source: Zacks Investment Research
What the Zacks Model Unveils for International PaperOur proven model does not conclusively predict an earnings beat for International Paper this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, but that is not the case here.
IP’s Earnings ESP: International Paper has an Earnings ESP of 0.00%. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Zacks Rank of International Paper: The company currently has a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Factors Likely to Have Shaped IP’s Q3 PerformanceInternational Paper’s second-quarter 2026 performance was adversely affected by elevated maintenance outage costs of $205 million, which was the heaviest outage quarter of the year. The company had projected maintenance outage expenses of $79 million for the third quarter. The anticipated decline in maintenance-related costs is likely to have supported sequential earnings growth in the third quarter.
However, higher transportation and fuel costs are expected to have increased input costs sequentially, putting pressure on margins. These headwinds are likely to have been partially offset by favorable volume trends, the realization of previously announced price increases and savings from the company’s 80/20 initiatives. These initiatives aim to simplify operations, eliminate fixed costs and direct resources toward higher-return assets.
International Paper projected third-quarter adjusted EBITDA from continuing operations of $780-$830 million, including an estimated $85 million negative impact from the temporary suspension of operations at its Pine Hill mill for roof repairs. Our model estimates adjusted EBITDA of $810.5 million for the quarter, up from $587 million in the second quarter of 2026. However, the projected figure implies a 6% decline from the year-ago quarter.
Our Projections for International Paper’s Segments in Q3For the Packaging Solutions North America segment, third-quarter 2026 price and mix are expected to have improved sequentially, reflecting the realization of previously announced price increases. Volumes were projected to decline sequentially, as the benefit of an additional shipping day was likely to have been offset by lower export volumes.
Our model projects Packaging Solutions North America’s net sales at $3.93 billion for the third quarter of 2026, reflecting a 7% increase sequentially and an 0.8% increase year-over-year.
Operations and costs are expected to have been favorable sequentially. Benefits from the Riverdale ramp-up and the contribution from the NORPAC acquisition are expected to have more than offset lower Ixtac insurance proceeds anticipated in the third quarter. Input costs are expected to have been unfavorable due to higher OCC costs and seasonally higher energy costs.
Taking these factors into account, along with the temporary suspension of the Pine Hill mill, management projected third-quarter adjusted EBITDA of $555-$585 million for the segment. Our model estimates adjusted EBITDA of $570.8 million, up 33% sequentially but down 14.2% year over year.
For Packaging Solutions EMEA, volumes were expected to increase sequentially, supported by seasonal demand patterns and customer wins. Price and mix were also likely to contribute positively, driven by the continued realization of previously announced paper price increases and the corresponding recovery in box pricing.
Our model projects the segment’s third-quarter net sales at $2.38 billion, indicating a 4% sequential increase and a 3% rise from the year-ago quarter.
Operations and costs are expected to have improved sequentially, supported by progress on the company’s cost-out initiatives and lower distribution costs. Input costs are expected to have been unfavorable as lower OCC costs were largely offset by higher energy costs, including the non-repeat of the energy subsidies received in the second quarter. Based on these factors, management expected third-quarter adjusted EBITDA of $230-$250 million for the segment. Our model estimates adjusted EBITDA of $249.7 million, up 37% sequentially and 19.5% from the year-ago quarter.
International Paper Stock's Price PerformanceInternational Paper's shares have lost 31.1% in the past year compared with the industry's 14.1% decline.
Image Source: Zacks Investment Research
Stocks Poised to Beat EstimatesHere are some Basic Materials stocks, which according to our model, have the right combination of elements to post an earnings beat in their upcoming releases.
Air Products and Chemicals (APD - Free Report) , scheduled to release third-quarter 2026 earnings on Nov. 5, has an Earnings ESP of +0.44% and a Zacks Rank of 3 at present.
The Zacks Consensus Estimate for earnings for Air Products and Chemicals for the third quarter of 2026 is pegged at $3.60 per share, suggesting a 6.2% year-over-year increase. APD has a trailing four-quarter average earnings surprise of 2.9%.
Avient (AVNT - Free Report) , scheduled to release third-quarter 2026 earnings on Nov. 4, has an Earnings ESP of +0.58% and a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for earnings for Avient for the third quarter of 2026 is 81 cents per share, indicating a 15.7% year-over-year increase. Avient has a trailing four-quarter average earnings surprise of 3.4%.
Perimeter Solutions, SA (PRM - Free Report) , scheduled to release third-quarter 2026 earnings on Nov. 5, has an Earnings ESP of +3.16% and a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for Perimeter Solutions’ earnings for the third quarter of 2026 is pegged at 95 cents per share, indicating 15.8% growth from the year-ago quarter's reported figure. PRM has a trailing four-quarter average earnings surprise of 61.6%.
UFP Industries koupí provozní aktiva výrobce palet Apache Products za přibližně 27 milionů USD; akvizice přidá zhruba 55 milionů USD ročních tržeb a do společnosti přibude 165 zaměstnanců.
, /PRNewswire/ -- UFP Industries, Inc. (Nasdaq: UFPI) today announced the acquisition of the operating assets, including real estate, of Apache Products, Inc. dba Acme Skid, a pallet manufacturer based in Silsbee, Texas, for approximately $27 million. The transaction expands UFP Packaging's pallet manufacturing footprint and strengthens the company's ability to serve customers throughout the Gulf Coast, one of the country's largest industrial and petrochemical markets.
Apache Products designs and manufactures stringer and heat-treated pallets from its facility in Silsbee. The transaction adds approximately $55 million in annual sales and brings 165 employees into the UFP family. The addition strengthens a core business for UFP Industries and expands UFP Packaging's PalletOne network with immediate capacity and a strong platform for long-term growth.
"Apache is the kind of business we look for at UFP: an established market leader with long-standing customer relationships, a disciplined operation and an experienced team that has a proven track record of execution," said Will Schwartz, chief executive officer of UFP Industries. "This acquisition tracks with our other investments this year—broadening our reach into a strategically important geography and creating opportunities to grow with our national customers across the region to create long-term value."
The Apache facility will be integrated into UFP Packaging's existing pallet manufacturing network, creating opportunities to leverage UFP's operational scale, national customer relationships and broader packaging platform while maintaining the local expertise and customer focus that have defined Apache's success.
"The Gulf Coast is one of the country's most important industrial packaging markets, driven by concentrated manufacturing, energy and petrochemical activity," said Scott Worthington, president of UFP Packaging. "The team at Apache will expand our ability to support customers as they grow through greater efficiency, scale and access to a larger range of packaging solutions."
The acquisition underscores UFP Industries' continued focus on investing in core businesses, expanding manufacturing capacity to serve regional and national customers, and strengthening the competitive position of its operating companies across packaging and industrial markets. The transaction is expected to close on or around Nov. 16, 2026.
UFP Packaging is a leading provider of comprehensive industrial packaging solutions and the largest producer of wood pallets and crates in the United States. In addition to pallets, the company combines nationwide engineering and manufacturing expertise to develop custom, multi-material packaging systems that solve complex product protection and supply chain challenges. Its capabilities encompass structural and reusable metal packaging, custom and stock corrugated boxes, advanced printing and labeling, and other protective packaging solutions.
About UFP Industries
UFP Industries, Inc. (Nasdaq: UFPI) is a holding company whose operating subsidiaries manufacture, distribute and sell value-added products for the retail, construction and industrial markets throughout North America, Europe, Asia and Australia. Founded in 1955 and headquartered in Grand Rapids, Mich., UFP Industries is among North America's largest diversified manufacturers.
Společnost Entergy má za čtvrtletí končící v září 2026 vykázat zisk na akcii (EPS) ve výši 1,71 USD, což představuje meziroční nárůst o 11,8 %, při tržbách 4,16 mld. USD (+9 %).
The market expects Entergy (ETR - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on November 2, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis power company is expected to post quarterly earnings of $1.71 per share in its upcoming report, which represents a year-over-year change of +11.8%.
Revenues are expected to be $4.16 billion, up 9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 12.63% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Entergy?For Entergy, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.01%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that Entergy will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Entergy would post earnings of $0.94 per share when it actually produced earnings of $1.03, delivering a surprise of +9.57%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Entergy appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAnother stock from the Zacks Utility - Electric Power industry, Exelon (EXC - Free Report) , is soon expected to post earnings of $0.81 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -5.8%. Revenues for the quarter are expected to be $6.87 billion, up 2.4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Exelon has been revised 1% down to the current level. Nevertheless, the company now has an Earnings ESP of -1.86%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Exelon will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Proti společnosti AppLovin byla podána hromadná žaloba kvůli údajnému zkreslování pokroku jejích modelů umělé inteligence; akcie 6. srpna 2026 po zveřejnění tržeb za druhé čtvrtletí ve výši 1,92 mld. USD klesly o 19,66 %.
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AppLovin Corporation (NASDAQ: APP) that a class action has been filed on behalf of shareholders who purchased securities between February 12, 2026 and August 5, 2026. Check if you might be eligible to recover your investment losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
AppLovin reported second quarter 2026 revenue of $1.92 billion against consensus estimates of $1.94 billion. APP shares fell $82.13, or 19.66%, to close at $335.67 on August 6, 2026, down $171.31 from the Class Period high of $506.98 reached on July 12, 2026. The lead plaintiff deadline is November 16, 2026.
The Promise
The company projected a compounding growth engine: better AI models delivered better returns for advertisers, advertisers moved more budget onto the platform, and the resulting data improved the models again. On May 6, 2026, management described that mechanism as "a virtuous cycle, and it is working," told investors the Company had "100% seen faster improvements to the models, both across the consumer business and the gaming business," and added that "we don't really see a reason why that's going to slow down." On the same call, the generative AI video creative feature for the AppLovin Ads platform was described as in testing, with a plan to "roll it out to all accounts shortly."
The Reality
Results revealed a different picture on August 5, 2026. Management stated that the "pace of meaningful model improvement was lighter than normal during the quarter" and that the next step-up "landed just after quarter end." On the video tool, investors were told: "We're not at the point where we can yet get a high-quality video for 30 to 60 seconds in the hand of an advertiser out of the box. So that's still [a] work in progress."
Promise vs. Actual: By the Numbers
Promised in March 2026: a 20% to 30% growth framework supported by "directed model enhancements and recursive learning" occurring "on an ongoing basis." Actual: single-digit second quarter growth, the weakest of the prior 12 quarters.Promised in May 2026: the generative AI video tool rolled out "to all accounts shortly." Actual, August 5, 2026: "still [a] work in progress."Anticipated second quarter revenue: $1.94 billion. Reported: $1.92 billion.Class Period high: $506.98 per share. Close after the second quarter disclosure: $335.67 per share.During the Class Period, the individual defendants sold 260,065 shares for more than $109.1 million in proceeds, the complaint alleges. The gap demonstrates, according to the lawsuit, that the constancy of AI model improvement and the readiness of the video tool were overstated while investors purchased at allegedly inflated prices.
"Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The complaint alleges that AppLovin investors were told model gains had no reason to slow down weeks before the Company reported that the pace of meaningful improvement had been lighter than normal." -- Joseph E. Levi, Esq.
Learn more about the case or call (212) 363-7500.
Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com | Attorney Advertising. Prior results do not guarantee similar outcomes.
Frequently Asked Questions About the APP Lawsuit
Q: What specific misstatements does the APP lawsuit allege? A: The complaint alleges AppLovin made materially false or misleading statements regarding the constancy and reliability of improvements to its AI advertising models and the development status of its generative AI video creative tool during the Class Period. When the Company reported second quarter revenue of $1.92 billion, disclosed that the pace of meaningful model improvement had been "lighter than normal," and described the video tool as "still [a] work in progress," the stock price declined sharply.
Q: When did AppLovin allegedly mislead investors? A: The Class Period runs from February 12, 2026 to August 5, 2026. The complaint alleges that corrective disclosures revealed information that caused a significant stock decline.
Q: What court was the APP class action filed in? A: The case was filed in the United States District Court for the Northern District of California, governed by the Private Securities Litigation Reform Act of 1995.
Q: What do APP investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.
Q: What documents do I need to to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if my APP losses are small -- is it still worth contacting a lawyer? A: Yes. There is no minimum loss amount required to participate as a class member.
Q: How long will the lawsuit take to resolve? A: Securities class actions typically take two to four years from initial filing to resolution. Timing depends on the court schedule, case developments, and whether the matter is dismissed, settled, or litigated further.
Q: Can I join a different law firm's lawsuit instead? A: Yes. Investors may choose which law firm to contact. Multiple firms often file competing complaints. The court may consolidate related cases and appoint a single lead counsel.
Huntsman (HUN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on November 2, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis chemical company is expected to post quarterly earnings of $0.07 per share in its upcoming report, which represents a year-over-year change of +333.3%.
Revenues are expected to be $1.6 billion, up 9.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.22% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Huntsman?For Huntsman, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +36.14%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Huntsman will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Huntsman would post earnings of $0.06 per share when it actually produced break-even earnings, delivering a surprise of -100.00%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Huntsman appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Chemical - Diversified industry, LyondellBasell (LYB - Free Report) , is soon expected to post earnings of $2.73 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +170.3%. This quarter's revenue is expected to be $8.47 billion, up 9.7% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for LyondellBasell has been revised 8.2% up to the current level. Nevertheless, the company now has an Earnings ESP of -1.18%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that LyondellBasell will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Léčba brezosiranem od společnosti Alnylam po jedné dávce snížila hladinu mutantního huntingtinu v mozkomíšním moku v průměru o 60–64 %, u jednotlivců až o 83 %; klíčovou studii společnost plánuje na rok 2027.
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite DirectionsAlnylam Pharmaceuticals NASDAQ: ALNY outlined early clinical data for brezosiran, an investigational RNA interference therapy for Huntington’s disease, reporting dose-dependent reductions in cerebrospinal fluid mutant huntingtin after a single intrathecal dose and plans to begin a placebo-controlled pivotal study in 2027, pending regulatory alignment.
Get ALNY alerts:
Huntington’s disease is a progressive, fatal inherited neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene. The disease can affect movement, cognition and mood, and Alnylam estimates that more than 100,000 symptomatic patients live globally. There are currently no approved disease-modifying treatments.
Exon 1 Strategy Targets Multiple Huntingtin Forms Alnylam Stock Soars 65%: Find Out What’s Behind the GainsBrezosiran, previously called ALN-HTT02, is designed to target a sequence in Exon 1 of the huntingtin gene. Alnylam said this approach is intended to reduce both full-length mutant huntingtin and a shorter form known as huntingtin 1a, as well as wild-type huntingtin.
Kevin Sloan, Alnylam’s vice president of development programs and program lead for brezosiran, said prior huntingtin-lowering programs have often targeted sequences downstream of Exon 1, meaning they may lower full-length huntingtin without directly addressing huntingtin 1a.
3 biotech powerhouses poised to thrive amid sector rebound“We ultimately selected” an inclusive Exon 1-targeting approach “designed to lower all relevant huntingtin species in the CNS,” Sloan said.
Gill Bates, professor of molecular neuroscience and co-director of the Huntington’s Disease Centre at University College London, discussed research suggesting huntingtin 1a may contribute meaningfully to disease biology. She said somatic expansion of the CAG repeat in vulnerable neurons is believed to be an early event in Huntington’s disease pathogenesis.
Bates described three mouse-model studies published this year that examined the effects of reducing huntingtin 1a. In one study, preventing production of huntingtin 1a delayed aggregation and normalized certain cerebrospinal fluid biomarkers while full-length mutant huntingtin remained present. Other studies found that approaches lowering huntingtin 1a alongside full-length mutant huntingtin had larger effects on aggregation and transcriptional dysregulation than approaches aimed only at full-length huntingtin.
However, Bates said it remains difficult to measure huntingtin 1a in living patients because it may be produced in relatively small populations of cells with highly expanded repeats and may remain trapped in cellular aggregates. She said reductions in full-length huntingtin could potentially serve as an indirect indicator of huntingtin 1a lowering for therapies directed at Exon 1.
Initial Phase Ib Data Showed Up to 83% Individual Reductions Toby Ferguson, Alnylam’s senior vice president and head of neuroscience, presented initial results from an ongoing randomized, double-blind, placebo-controlled phase Ib study in patients with stage 2 or early stage 3 Huntington’s disease. The trial enrolled patients between ages 25 and 70 with more than 39 CAG repeats in Canada, Germany and the United Kingdom.
The data cut included five dose cohorts with up to three months of follow-up after one intrathecal administration of brezosiran. The study’s primary endpoint is safety and tolerability, while secondary measures include cerebrospinal fluid and plasma pharmacokinetics and changes in cerebrospinal fluid mutant huntingtin.
Using two assays, including a newer mutant huntingtin NULISA assay, Alnylam reported dose-dependent reductions in cerebrospinal fluid mutant huntingtin. At the highest evaluated dose, the company reported mean reductions of 60% to 64% at month three, with maximum individual reductions of up to 83%.
Ferguson said the NULISA assay avoided lower-limit-of-quantification issues observed with a traditional assay, particularly after deeper huntingtin lowering.
Safety Findings and Development Plans Alnylam said adverse events occurred in most participants, as is common in neurodegenerative-disease studies, but reported no dose-related increase in serious or severe adverse events across the five cohorts. There were no deaths or treatment discontinuations due to adverse events.
The company reported two severe and serious events in one dose group: a radius fracture and likely bacterial meningitis. It also reported an acute myocardial infarction that resolved with sequelae and a resolved post-lumbar puncture syndrome in that same dose group. A severe, non-serious headache in another group had resolved.
Ferguson said cerebrospinal fluid white blood cell counts and protein levels were similar between treated and placebo participants, with no evidence to date of dose-related central nervous system inflammation. The company also reported no dose-dependent increases in cerebrospinal fluid neurofilament light chain, a biomarker associated with neuronal injury, and no dose-dependent changes in ventricular volume on MRI.
“Our findings to date do not establish clinical efficacy,” Ferguson said, adding that longer and larger studies will be required.
Participants may enter an open-label extension in which they can receive brezosiran every six months. Alnylam said the extension will help characterize longer-term safety and explore potential efficacy trends, though Ferguson said it may take 24 to 36 months to meaningfully assess clinical effects in Huntington’s disease.
The company plans to pursue a placebo-controlled pivotal study beginning in 2027, subject to regulatory discussions. Alnylam said the trial is intended to determine whether brezosiran can slow disease progression and would, to its knowledge, be the first placebo-controlled test of the huntingtin 1a-lowering hypothesis.
About Alnylam Pharmaceuticals (NASDAQ:ALNY)Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and commercializing medicines based on RNA interference (RNAi). The company's therapies are designed to silence specific genes involved in disease, with the goal of addressing the underlying causes of genetic and other serious conditions.
Alnylam's marketed products include ONPATTRO (patisiran) and AMVUTTRA (vutrisiran) for hereditary transthyretin-mediated amyloidosis, GIVLAARI (givosiran) for acute hepatic porphyria, and OXLUMO (lumasiran) for primary hyperoxaluria type 1.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Alnylam Pharmaceuticals Right Now?Before you consider Alnylam Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alnylam Pharmaceuticals wasn't on the list.
While Alnylam Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Key Takeaways Ameriprise's Q3 earnings and revenues are projected to rise 16.9% and 9.1% y/y, respectively.AMP's AUM and AUA are expected to grow 6.3% to $1.76T, supported by overall net inflows.Ameriprise's fee income growth may aid Q3 results, while higher technology and hiring costs could weigh. Ameriprise Financial, Inc. (AMP - Free Report) is slated to announce third-quarter 2026 results on Oct. 29, before market open. Its quarterly revenues and earnings are expected to have risen year over year.
In the last reported quarter, AMP’s earnings beat the Zacks Consensus Estimate. An increase in revenues, and higher assets under management (AUM) and assets under administration (AUA) balances acted as tailwinds. Conversely, an increase in expenses was a headwind.
Ameriprise has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average beat being 5.6%.
Q3 Estimates & Key Factors to Note for AmeripriseThe Zacks Consensus Estimate for AMP’s management and financial advice fees (constituting more than 60% of total net revenues) is pegged at $3.18 billion, suggesting a 13.2% rise from the prior-year quarter’s reported number.
The consensus estimate for distribution fees of $582 million indicates a year-over-year increase of 8%. The consensus mark for other revenues of $141 million suggests 8.5% growth.
The consensus estimate for premiums, policy and contract charges is pegged at $380 million, implying a year-over-year rise of 22.9%.
Alternatively, the consensus estimate for net investment income of $836 million suggests a year-over-year decline of 9.1%.
Overall net inflows are expected to have driven the company’s total AUM and AUA balance. The Zacks Consensus Estimate for total AUM and AUA is pegged at $1.76 trillion, indicating a rise of 6.3% from the year-ago quarter’s actual.
While Ameriprise’s initiatives to focus on cost management have led to controlled general and administration expenses, overall costs are anticipated to have been elevated in the to-be-reported quarter due to those related to technology upgrades and hirings.
Earnings Whispers for AmeripriseAccording to our proven model, the chances of Ameriprise beating the Zacks Consensus Estimate for earnings are low this time around. This is because it does not have the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better, which is required to be confident of an earnings surprise call.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: Ameriprise has an Earnings ESP of +0.38%.
Zacks Rank: The company currently carries a Zacks Rank #4 (Sell).
Ameriprise’s Q3 Earnings & Sales EstimatesThe Zacks Consensus Estimate for the company’s quarterly earnings is pegged at $11.60 per share, which indicates a rise of 16.9% from the prior-year quarter’s actual. The consensus estimate has been unchanged over the past seven days.
The consensus estimate for total quarterly sales is pegged at $5.03 billion, which suggests a 9.1% year-over-year increase.
Finance Stocks Worth a LookHere are a couple of finance stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time:
The Earnings ESP for Robinhood Markets (HOOD - Free Report) is +0.22% and it flaunts a Zacks Rank #1 (Strong Buy) at present. The company is expected to report third-quarter 2026 results on Oct. 27. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past seven days, the Zacks Consensus Estimate for HOOD’s quarterly earnings has been revised higher to 56 cents per share.
BGC Group, Inc. (BGC - Free Report) is scheduled to announce quarterly results on Nov. 5. The company currently has an Earnings ESP of +1.49% and a Zacks Rank #2 (Buy).
Quarterly earnings estimates for BGC have been unchanged at 34 cents per share over the past week.
Alliance Resource Partners zvýšila tržby ve třetím čtvrtletí o 5,5 % na 603 mil. USD a čistý zisk o 46,8 % na 139,6 mil. USD díky vyšším dodávkám uhlí.
3 Stocks Using Bitcoin to Grow Their Treasury ReservesAlliance Resource Partners NASDAQ: ARLP reported higher third-quarter 2026 revenue, earnings and adjusted EBITDA, supported by stronger coal shipments, the return of longwall production at its Hamilton mine and the first full-quarter contribution from its AllDale III and IV oil-and-gas royalty acquisition.
Total revenue increased 5.5% from a year earlier to $603 million. Net income attributable to ARLP rose 46.8% to $139.6 million, or $1.08 per basic and diluted limited partner unit, while adjusted EBITDA attributable to ARLP increased 26.3% to $233.9 million.
Get ARLP alerts:
Peabody Energy is a Double Threat Energy and Steel Play Results also improved sequentially from the second quarter. Revenue rose 9.3%, net income increased 75.5%, and adjusted EBITDA attributable to ARLP grew 26.4%.
The partnership said net income benefited from a $16.5 million increase in the fair value of digital assets and a $6.3 million non-cash gain from remeasuring its prior equity interest in AllDale III following the acquisition of AllDale III and IV. Those gains were partly offset by higher income-tax expense and a $7.3 million loss on derivative instruments assumed in the acquisition, including $6.7 million that was unrealized.
3 High-Yield Energy MLPs: A Stable Way to Invest in EnergyBeginning this quarter, ARLP changed its adjusted EBITDA presentation to include non-controlling interests and report adjusted EBITDA attributable to ARLP, excluding amounts attributable to non-controlling interests in AllDale III and IV and Cavalier Minerals. Prior-period figures were adjusted to conform with the revised presentation.
Coal operations benefit from higher volumes and lower costs Coal sales volumes reached 9.3 million tons, up 7.4% year over year and 9.2% sequentially. Coal segment adjusted EBITDA increased 18.6% from the prior-year quarter to $186.8 million, as higher volumes and lower expenses per ton outweighed lower average realized pricing.
Average coal sales price declined 8.3% year over year to $53.93 per ton, primarily because of a larger mix of lower-priced Tunnel Ridge volumes. Segment adjusted EBITDA expense per ton improved 13.1% to $35.64. The resulting spread between sales price and EBITDA expense widened to $18.29 per ton from $16.19 per ton in the second quarter.
In the Illinois Basin, volumes increased 6.4% year over year to 7 million tons, driven by Hamilton’s resumption of longwall production. Illinois Basin adjusted EBITDA rose 32.6% to $139.8 million, while adjusted EBITDA expense per ton fell 10.2% to $31.77.
Appalachia coal sales volumes climbed 10.7% to 2.3 million tons on strong Tunnel Ridge sales. However, average pricing in the region fell 25.1% to $62.35 per ton due to the larger Tunnel Ridge sales mix. Appalachia expense per ton improved 19.9% to $46.25.
Chairman, President and Chief Executive Officer Joe Craft said Hamilton set monthly production records in July and August after returning from an extended move and was the company’s lowest-cost operation during the quarter. He said the fourth quarter’s Illinois Basin cost performance should be comparable, while 2027 should benefit from a full year of Hamilton production.
Mettiki agreement restores production plans ARLP also announced a new multiyear coal supply agreement for its Mettiki operation, which had suspended mining after the partnership issued a WARN notice during the first quarter. The agreement will allow the mine and nearly 150 miners to return to production.
The mine is transitioning from longwall mining to two room-and-pillar sections operating two shifts per day by the end of the first quarter of 2027. ARLP expects Mettiki’s 2027 production to be about 550,000 tons higher than its 2026 production, with lower EBITDA expense per ton.
Craft said the agreement with Mettiki’s largest historical customer reflected the mine’s importance to the customer’s security of coal supply as it evaluates electricity demand tied to data-center contracts. He added that the revised mining approach could provide flexibility to participate selectively in the export metallurgical coal market.
ARLP said it added 4.2 million committed and priced coal tons through 2028 during the quarter. It has 31.7 million tons committed and priced for 2027, including 700,000 tons related to Mettiki’s new agreement. Export commitments total 3.7 million tons for 2026 and 3 million tons for 2027.
Craft said export volumes have exceeded expectations, although barge capacity constraints and higher transportation costs could limit growth. If logistics conditions improve, he said ARLP could potentially exceed this year’s coal sales volumes by 500,000 to 1 million tons without additional investment or operational changes.
Royalty business posts record revenue and volumes Total royalty revenue rose 52.5% year over year to $87.5 million, while royalty segment adjusted EBITDA attributable to ARLP increased 40% to $61.8 million.
The oil-and-gas royalty segment recorded quarterly records of $59.8 million in revenue and 1.45 million barrels of oil equivalent in volumes, largely reflecting the AllDale III and IV acquisition. Oil-and-gas royalty adjusted EBITDA attributable to ARLP increased 61.4% from a year earlier to $43.6 million.
Average sales price per barrel of oil equivalent rose 15.5% year over year to $41.21, as higher realized crude prices more than offset a greater natural-gas weighting after the acquisition. Sequentially, the average price declined 16.6% due to lower realized crude prices and the higher natural-gas mix.
Chief Financial Officer Cary Marshall said ARLP expects volume growth in 2027 even without further acquisitions, while also continuing to pursue royalty acquisitions and reinvest cash flow from the business. The partnership is completing reserve studies and expects to provide 2027 guidance with fourth-quarter results in February.
Cash flow strengthens as company tightens outlook Free cash flow totaled $198.6 million in the quarter, while distributable cash flow rose about 29% from a year earlier to $136.8 million. Distribution coverage increased to 1.76 times.
At Sept. 30, total debt and finance leases stood at $679.9 million, with net debt of $595 million. Total and net leverage were 0.89 times and 0.78 times trailing 12-month adjusted EBITDA attributable to ARLP, respectively. The partnership ended the quarter with $430.8 million of liquidity and held 673 Bitcoin valued at $56.3 million.
Marshall said ARLP expects to amortize a new $150 million, 18-month minerals debt facility using cash flow from its minerals business. Craft said the partnership intends to maintain distribution coverage of at least 1.5 times on a sustained basis before considering an increase in its distribution.
For 2026, ARLP tightened its coal guidance and now expects sales volumes of 34.5 million to 35.5 million tons, coal sales pricing of $54.25 to $54.75 per ton, and segment adjusted EBITDA expense of $37.50 to $38.50 per ton.
About Alliance Resource Partners (NASDAQ:ARLP)Alliance Resource Partners, L.P. NASDAQ: ARLP is a diversified natural resource company headquartered in Tulsa, Oklahoma. The company's primary business is the production and marketing of coal, which it supplies to electric utilities and industrial customers in the United States.
Alliance Resource Partners operates coal mines in the Illinois Basin and Appalachia, producing primarily thermal coal used for electricity generation. Its operations include underground and surface mining, coal processing, transportation and marketing activities.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Alliance Resource Partners Right Now?Before you consider Alliance Resource Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alliance Resource Partners wasn't on the list.
While Alliance Resource Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
KING OF PRUSSIA, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), the Decision-to-Defense™ global indirect tax and compliance company, today introduced Vertex Sōl™, a connected compliance experience that brings intelligence, workflows, decisions, and evidence together across the tax lifecycle. The transaction is the atomic unit of commerce. Vertex Sōl ties tax and compliance to each transaction, from determination through e-invoicing, reporting, and defense, creating one continuous, governed record.
It helps tax teams see potential issues sooner and understand their impact, while they stay in control of what happens next. Taking its name from sōl, Latin for sun, it not only provides full visibility into indirect tax and compliance AI workflows but also acts as the center of gravity where humans govern the work through one system of control from decision to defense.
Vertex Sōl connects the Vertex solutions trusted by a customer base including more than 60% of the Fortune 500, from the first tax decision through audit. Vertex Intelligence™ powers the AI capabilities within Vertex Sōl, bringing forward trusted tax expertise, global regulatory intelligence, explanations, and recommendations so that tax professionals have the evidence they need to stand behind the outcome.
"Tax professionals have carried the burden of the work around the tax decision — researching, reconciling, documenting, and defending," said Bala Chandran, Chief Product and Technology Officer at Vertex. "Vertex Sōl changes that. It begins at the decision inside the transaction and carries it forward on one record. It is led by AI that can be governed, explained, and defended, so tax professionals can command the outcome instead of the manual work around it."
The roll-out comes as enterprises reassess how far AI should be trusted in tax and compliance. In a Vertex-commissioned survey of 402 tax and compliance software decision makers in the U.S. and Germany, conducted by Emerald Research Group, 81% of respondents said they would only be comfortable adopting AI in compliance if they had full visibility into how automated decisions were made, and could override or reverse any action at any time.
Vertex Sōl is designed to support graduated levels of trust, so tax teams can determine when AI recommends a course of action, assists with the work, or acts within defined controls they set. At every level, teams retain insight into how decisions are made and the ability to review, override, or reverse actions.
“Trust has always been fundamental to tax and compliance, and AI raises the stakes,” said Christopher Young, CEO of Vertex. “Tax teams need to be able to see what’s happening, understand what matters, and stay in control. Vertex Sōl combines that visibility with the tax content, intelligence, and expertise our customers have relied on for decades, so they can put AI to work with confidence.”
Vertex Sōl in Action
Across the tax and compliance lifecycle, Vertex Sōl will help teams navigate existing and future capabilities across moments such as:
When a rule changes: Connect across regulatory intelligence and content, assess potential impact, and surface information for professional review. Before filing: Bring together proactive surfacing of relevant issues, explanation of potential impact, and recommendations within defined controls. When an auditor calls: Streamline organizing the audit notice management process, enable evidence gathering, and make gaps visible for the team or advisors to review.
Industry analysts expect visibility and control to shape how enterprises choose AI for tax and compliance. "As AI agents take on more tax and compliance work, enterprises will judge vendors less on how many agents they offer and more on whether each action can be governed, explained, and traced back to the original decision," said Kevin Permenter, Senior Director, Enterprise Applications Research at IDC. "That kind of traceability is fast becoming a baseline expectation for AI in regulated finance functions."
Vertex Sōl is designed to connect work across tax determination, certificate management, e-invoicing, indirect tax close, reporting and filing, and audit and notice management. The resulting connected record will help teams trace outcomes back to the original transaction and tax decision, making them easier to explain, govern, and defend. For more information, click here.
About Vertex
Vertex is the Decision-to-Defense™ global indirect tax and compliance company. Vertex helps enterprises bring control to indirect tax and compliance across the full transaction lifecycle — from tax determination and e-invoicing through reporting, filing, and audit defense — to make outcomes easier to prove and improve over time. Trusted by more than 60% of the Fortune 500, Vertex combines decades of tax expertise, deep global tax and compliance knowledge, and embedded integrations to help organizations operate globally with confidence. With headquarters in North America and offices in South America and Europe, Vertex's purpose is to ensure businesses and communities thrive through trusted transactions.
For more information, visit www.vertexinc.com or follow us on X and LinkedIn; or subscribe on YouTube.
About the Research
The AI-visibility finding is from a double-blind online survey conducted by Emerald Research Group on behalf of Vertex in 2026 among 402 decision makers (n=302 US; n=100 Germany) at enterprises with $150M+/€150M+ in revenue and authority over enterprise tax and compliance software. Respondents were not informed of the study’s sponsor.
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Based in Cincinnati, Phillips Edison & Company, Inc. (PECO - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 7.84%. Currently paying a dividend of $0.35 per share, the company has a dividend yield of 3.6%. In comparison, the REIT and Equity Trust - Retail industry's yield is 4.37%, while the S&P 500's yield is 1.33%.
Looking at dividend growth, the company's current annualized dividend of $1.38 is up 10.1% from last year. Over the last 5 years, Phillips Edison & Company, Inc. has increased its dividend 5 times on a year-over-year basis for an average annual increase of 4.79%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Phillips Edison & Company's current payout ratio is 48%, meaning it paid out 48% of its trailing 12-month EPS as dividend.
Earnings growth looks solid for PECO for this fiscal year. The Zacks Consensus Estimate for 2026 is $2.77 per share, representing a year-over-year earnings growth rate of 6.54%.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. It's important to keep in mind that not all companies provide a quarterly payout.
Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, PECO is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
Společnost Fortive má ve třetím čtvrtletí vykázat tržby ve výši 1,06 miliardy USD, což představuje meziroční nárůst o 3 %, a zisk na akcii (EPS) ve výši 70 centů, meziročně o 2,94 % více.
Key Takeaways Fortive is set to report Q3 earnings on Oct. 28, with revenues expected to rise 3% and EPS to grow 2.94%.Strong demand for Fluke's data center solutions and recurring services may boost Q3 results.FTV faces pressures from unfavorable product mix, higher growth investments and cautious hospital spending.
Fortive Corporation (FTV - Free Report) is scheduled to report third-quarter 2026 results on Oct. 28.
The Zacks Consensus Estimate for revenues is pegged at $1.06 billion, which implies an increase of 3% from the year-ago reported number. The consensus mark for earnings is pegged at 70 cents per share, indicating year-over-year growth of 2.94%.
FTV’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 9.82%.
Fortive’s shares have gained 22.3% compared with the Electronics - Testing Equipment industry’s growth of 21.8% in the past year.
Image Source: Zacks Investment Research
Factors to Note Ahead of FTV’s Q3 ResultsFortive is expected to have benefited from sustained momentum across its industrial technologies, software and healthcare businesses, supported by healthy demand for data center solutions, AI-enabled offerings and recurring services. The company continues to execute its Fortive Accelerated strategy, focusing on faster profitable organic growth through innovation, commercial investments and recurring customer value, alongside disciplined capital allocation.
The company is witnessing healthy demand across its Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments. Within IOS, Fluke continues to benefit from robust demand for professional instrumentation, particularly in data centers and defense. Strong adoption of CertiFiber Max, which supports high-density fiber testing, is driving demand for Fluke's broader portfolio of network testing, power quality and battery testing solutions. Fluke's orders outpaced revenues in the second quarter, with a book-to-bill ratio above one, indicating healthy demand momentum.
The Facilities and Asset Lifecycle Solutions business is benefiting from strong demand for multisite facility maintenance and marketplace software, particularly at ServiceChannel. Improving performance at Accruent, solid contributions from Gordian and growing adoption of AI-enabled software offerings are likely to have supported third-quarter revenues. Strength in recurring services, including Fluke's calibration, maintenance and software offerings, remains another positive.
Within AHS, Fortive is benefiting from sustained demand for healthcare consumables, services and software solutions. ASP's consumables and services business recorded growth across all major regions in the second quarter, particularly the Asia-Pacific and Latin America. The low-temperature sterilization capital business also returned to growth amid gradually improving hospital spending conditions.
Moreover, FDA clearance for STERRAD's expanded 50-pound load capacity has strengthened ASP's position in robotic-assisted surgery applications. The acquisition of a majority stake in UV Smart further expands its disinfection portfolio. Strong demand for Provation's gastrointestinal documentation and SaaS offerings is another positive. These factors are expected to have supported the segment's third-quarter performance.
The Zacks Consensus Estimate for sales of the IOS and AHS segments is pegged at $733 million and $338 million, respectively, for the third quarter.
Fortive's operational discipline, structural cost savings and Fortive Business System-led productivity initiatives continue to support profitability. The company delivered 12% adjusted EBITDA growth and 110 basis points of adjusted EBITDA margin expansion in the second quarter. Continued cost optimization, operating leverage and disciplined capital allocation, including share repurchases, are likely to have supported third-quarter earnings.
However, Fortive expects third-quarter adjusted EBITDA margin to decline slightly sequentially due to seasonally lower revenues, strategic growth investments and tougher year-over-year operating expense comparisons. Unfavorable product mix across both segments is also expected to have pressured gross margins. Macroeconomic uncertainty in Europe, supply-chain challenges involving memory chips and rare-earth materials, and cautious hospital capital spending remain concerns. Management expects third-quarter adjusted earnings per share to increase marginally year over year, with earnings growth weighted toward the fourth quarter.
What Does Our Model Unveil for FTV?Our proven model does not predict an earnings beat for Fortive this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That is not the case here.
Fortive has an Earnings ESP of +0.58% and a Zacks Rank #4 (Sell) at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to ConsiderHere are a few stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
Seagate Technology Holdings plc (STX - Free Report) has an Earnings ESP of +2.07% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
STX is scheduled to report quarterly figures on Oct. 27, 2026. The Zacks Consensus Estimate for Seagate Technology’s to-be-reported quarter’s earnings and revenues is pinned at $7.44 per share and $4.11 billion, respectively. Its shares are up 175.4% in the past year.
Intel (INTC - Free Report) currently has an Earnings ESP of +2.22% and a Zacks Rank #2. INTC is scheduled to report quarterly earnings on Oct. 29, 2026. The Zacks Consensus Estimate for Intel’s to-be-reported quarter’s earnings and revenues stands at 39 cents per share and $16.44 billion, respectively. Its shares have gained 119.9% in the past year.
Vertiv (VRT - Free Report) has an Earnings ESP of +0.74% and a Zacks Rank #2 at present. The company is scheduled to report quarterly figures on Oct. 28, 2026. The Zacks Consensus Estimate for Vertiv’s to-be-reported quarter’s earnings and revenues is pinned at $1.82 per share and $3.76 billion, respectively. Its shares are up 0.8% in the past year.
Společnost Otter Tail očekává za čtvrtletí končící v září 2026 zisk 1,57 USD na akcii, což by znamenalo meziroční pokles o 15,6 %, při tržbách ve výši 335,7 milionu USD.
Otter Tail (OTTR - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 2. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis power company and manufacturer is expected to post quarterly earnings of $1.57 per share in its upcoming report, which represents a year-over-year change of -15.6%.
Revenues are expected to be $335.7 million, up 3.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 10.99% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Otter Tail?For Otter Tail, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Otter Tail will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Otter Tail would post earnings of $1.48 per share when it actually produced earnings of $1.66, delivering a surprise of +12.16%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Otter Tail doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerXcel Energy (XEL - Free Report) , another stock in the Zacks Utility - Electric Power industry, is expected to report earnings per share of $1.39 for the quarter ended September 2026. This estimate points to a year-over-year change of +12.1%. Revenues for the quarter are expected to be $4.15 billion, up 5.9% from the year-ago quarter.
The consensus EPS estimate for Xcel has been revised 2.9% lower over the last 30 days to the current level. However, an equal Most Accurate Estimate has resulted in an Earnings ESP of 0.00%.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Xcel will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - October 26, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Defendants had materially overstated aftermarket demand for their Opteon products; (ii) demand for such products was decreasing as a result of Defendants' overselling Opteon products in the preceding fiscal year; (iii) as a result of these undisclosed issues, Defendants' financial guidance for the 2026 fiscal year was unreliable; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On August 4, 2026, after market hours, Chemours announced second quarter 2026 financial results, including a reduction of its adjusted EBITDA full-year guidance to $775 million to $825 million (from $800 million to $900 million previously), and management admitted that "[a]s a result of the initial channel fill, aftermarket customers built additional inventory, creating an oversupplied channel heading into 2026." On this news, Chemours's stock price fell $3.34 per share, or 18.63%, to close at $14.59 per share on August 5, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding The Chemours's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the The Chemours class action, go to www.faruqilaw.com/CC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the The Chemours Securities Class Action Lawsuit:
What is the The Chemours securities fraud lawsuit about?
The lawsuit alleges that The Chemours Company ("Chemours") and certain of its officers and directors made materially false and/or misleading statements and failed to disclose material information to investors during the Class Period. Specifically, the complaint alleges that Defendants materially overstated aftermarket demand for their Opteon products and concealed that demand was declining due to Defendants' alleged overselling of those products in the preceding fiscal year. As a result of these allegedly undisclosed issues, the complaint further alleges that Defendants' financial guidance for fiscal year 2026 was unreliable. On August 4, 2026, after market hours, Chemours allegedly revealed the truth when it announced reduced full-year adjusted EBITDA guidance and management acknowledged that aftermarket customers had built excess inventory following an initial channel fill, creating an oversupplied channel heading into 2026.
Who may be eligible to participate in the lawsuit?
Investors who purchased or otherwise acquired the common stock of The Chemours Company (NYSE: CC) on the open market between February 20, 2026 and August 4, 2026, inclusive, may be eligible to participate in this lawsuit. The class period encompasses all qualifying purchases made during those dates, and eligible investors are encouraged to review the complaint and assess their potential claims. Importantly, investors do not need to seek appointment as lead plaintiff in order to participate in the case or share in any potential recovery. Any investor who believes they may have suffered losses as a result of the alleged misconduct is encouraged to contact counsel to learn more about their rights and options.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff is a court-appointed representative who acts on behalf of all class members in directing the litigation, including making key decisions regarding litigation strategy and the selection of counsel. Any member of the proposed class may move the court for appointment as lead plaintiff, and the court will typically appoint the applicant or group of applicants who demonstrate the largest financial interest in the relief sought and who otherwise satisfy the requirements of the applicable law. The deadline to file a motion for appointment as lead plaintiff in this action is December 7, 2026. Critically, an investor need not serve as lead plaintiff to be a member of the class or to share in any recovery that may be obtained; class membership and any resulting recovery are available to all eligible investors regardless of whether they seek a leadership role in the case.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased The Chemours securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320927
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Proti společnosti Chemours (NYSE: CC) byla podána hromadná žaloba kvůli údajnému zkreslování poptávky po chladivech Opteon; poté, co společnost zveřejnila pokles objemu prodejů o 4 %, se její akcie během jediné seance propadly o 18,63 %.
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in The Chemours Company (NYSE: CC) that a securities fraud class action has been filed on behalf of shareholders who purchased securities between February 20, 2026 and August 4, 2026. Find out if you could qualify to recover your losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
Opteon refrigerant sales rose a record 37% in the fourth quarter of 2025. Two quarters later, company-wide volumes fell 4%, primarily on weaker Opteon aftermarket sales, and Chemours shares dropped 18.63% in a single session. Applications to serve as lead plaintiff must be filed by December 7, 2026.
At its core, this is a specialty chemical securities fraud case built on allegedly overstated Opteon aftermarket demand. The complaint alleges that the Company failed to disclose that aftermarket demand for its Opteon products was decreasing because those products had been oversold during the preceding fiscal year.
The U.S. AIM Act Factor
Congress enacted the American Innovation and Manufacturing Act in December 2020, and federal regulation has reshaped refrigerant demand since then. The law directed the U.S. Environmental Protection Agency to oversee a shift toward alternative refrigerants with a lesser ozone impact. According to the lawsuit, the stationary air conditioning transition under that law triggered an initial aftermarket channel fill in 2025 as distributors and technicians stocked up for new equipment installations.
The lawsuit contends that this surge left 2026 aftermarket sales lapping an unusually strong prior-year base. That base was allegedly inflated by customer stockpiling rather than lasting end-user demand.
Key Opteon Demand Securities Fraud Allegations for Shareholders
Record Opteon growth in late 2025 allegedly reflected aftermarket customers building extra inventory, not sustainable end-market consumption.Customers allegedly entered 2026 holding excess product, which left the aftermarket channel oversupplied as the new year began.Purchasing during 2025 supply constraints allegedly pulled aftermarket sales forward from 2026, leaving less demand for the year ahead.The Company cited reduced Opteon blend aftermarket sales in North America as the main driver of its 2026 volume decline.The alleged overselling centers on the Thermal & Specialized Solutions segment, which reports Opteon results and anchored the Company's growth story. "This case presents important questions about demand disclosure obligations in the specialty chemical sector, particularly when a regulatory transition sparks a one-time buying wave. The lawsuit claims that record Opteon sales in 2025 masked an oversupplied aftermarket channel that would weigh on the following year. Shareholders are entitled to understand whether reported growth reflects durable demand." -- Joseph E. Levi, Esq.
Submit your information here or call (212) 363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Frequently Asked Questions About the CC Lawsuit
Q: Who is eligible to join the CC investor lawsuit? A: Investors who purchased CC stock or securities between February 20, 2026 and August 4, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What specific misstatements does the CC lawsuit allege? A: The complaint alleges The Chemours Company made materially false or misleading statements during the Class Period regarding aftermarket demand for its Opteon refrigerant products. It also alleges the Company failed to disclose that 2025 sales had oversupplied the distribution channel heading into 2026. When second quarter 2026 results reporting lower Opteon aftermarket sales were disclosed, the stock price declined sharply.
Q: What court was the CC class action filed in? A: The case was filed in the United States District Court for the District of Delaware, governed by the Private Securities Litigation Reform Act of 1995.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What if I already sold my CC shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: How long will the lawsuit take to resolve? A: Securities class actions typically take two to four years from initial filing to resolution. Timing depends on the court schedule, case developments, and whether the matter is dismissed, settled, or litigated further.
Idexx Laboratories má ve čtvrtletí vykázat zisk na akcii ve výši 3,71 USD, což představuje meziroční nárůst o 9,1 %, při tržbách 1,19 miliardy USD (+7,5 %).
Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on November 2, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis Animal diagnostic and health care company is expected to post quarterly earnings of $3.71 per share in its upcoming report, which represents a year-over-year change of +9.1%.
Revenues are expected to be $1.19 billion, up 7.5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.17% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Idexx?For Idexx, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.59%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that Idexx will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Idexx would post earnings of $3.95 per share when it actually produced earnings of $4.27, delivering a surprise of +8.10%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Idexx appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Medical - Instruments industry, ClearPoint Neuro, Inc. (CLPT - Free Report) , is soon expected to post loss of $0.32 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -52.4%. Revenues for the quarter are expected to be $12.5 million, up 41.1% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for ClearPoint Neuro has remained unchanged. Nevertheless, the company now has an Earnings ESP of -14.29%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that ClearPoint Neuro will beat the consensus EPS estimate. The company could not beat consensus EPS estimates in any of the last four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Key Takeaways NI's Q3 earnings are likely to gain from load growth, data center demand and higher manufacturing activity.NI's Q3 EPS is projected to rise 15.8% to 22 cents, while revenues are expected to grow 9.5% to $1.39 billion.New rates, infrastructure investments and cost discipline are expected to support NI's results.
NiSource Inc. (NI - Free Report) is scheduled to release third-quarter 2026 results on Oct. 28, before market open. The company delivered an earnings surprise of 6.67% in the last reported quarter.
Let’s discuss the factors that are likely to be reflected in the upcoming quarterly results.
Factors That Might Have Impacted NI’s Q3 PerformanceNiSource's third-quarter earnings are expected to have benefited from rising load growth, data center demand and higher manufacturing activities. Customer growth and continued economic development across its service territories are expected to have supported revenues. New electric and gas rates implemented in previous quarters may have contributed to earnings growth.
NiSource’s focus on customer safety and continued investment in infrastructure development is likely to have supported its quarterly performance. Spending on electric transmission and gas systems to support incremental demand in its service territories is likely to have a positive impact on third-quarter earnings.
The company's continued emphasis on cost discipline and efforts to keep operation and maintenance expenses stable are expected to have helped maintain customer affordability and support its upcoming quarterly performance.
Q3 Expectations for NIThe Zacks Consensus Estimate for earnings is pegged at 22 cents per share, which implies a year-over-year rise of 15.8%.
The Zacks Consensus Estimate for revenues is pinned at $1.39 billion, indicating an increase of 9.5% from the year-ago reported number.
What Our Quantitative Model Predicts for NIOur proven model predicts an earnings beat for NiSource this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here, as you will see below.
Other Stocks to ConsiderHere we have mentioned other players from the same industry that also have the right combination of elements to beat on earnings this reporting cycle:
CenterPoint Energy, Inc. (CNP - Free Report) is scheduled to report its third-quarter 2026 results on Oct. 27, before market open. It has an Earnings ESP of +0.81% and a Zacks Rank of 3 at present.
CNP’s long-term (three to five years) earnings growth rate is 7.93%. The Zacks Consensus Estimate for earnings stands at 50 cents per share.
American Electric Power Company, Inc. (AEP - Free Report) is slated to report its third-quarter 2026 results on Oct. 28, before market open. It has an Earnings ESP of +4.67% and a Zacks Rank of 3 at present.
AEP’s long-term earnings growth rate is 7.40%. The Zacks Consensus Estimate for earnings stands at $2 per share, which implies a year-over-year jump of 11.1%.
Edison International (EIX - Free Report) is slated to report its third-quarter 2026 results on Oct. 29, after market close. It has an Earnings ESP of +1.12% and a Zacks Rank of 3 at present.
EIX’s long-term earnings growth rate is 3.86%. The Zacks Consensus Estimate for earnings is pegged at $1.79 per share.
